Years of Looking Forward

Faculty Krassi Ivancev, Hamburg, Germany Peter Schneider, Honolulu, USA Eddie Chaloner, London, UK Ralf Kolvenbach, Düsseldorf, Germany Andrea Agostinucci, Turin, Italy Heinz Jakob, Essen, Germany Catherine Shanahan, London, UK Sylvain Chastanet, Nice, France Peter Konstantiniuk, Graz, Austria Thomas Albrecht, Berlin, Germany Houman Jalaie, Aachen, Germany Cliff Shearman, Southampton, UK Fahd Chaudhry, Knoxville, USA Reinhard Kopp, Regensburg, Germany Jose Almeida, Miami, USA William Jeffcoate, Nottingham, UK Mitchell Silver, Columbus, USA Larysa Chernukha, Kiev, Ukraine Ali Kordzadeh, Broomfield, UK Klaus Amendt, Mannheim, Germany Robert Jones, Birmingham, UK Konstantinos Spanos, Larissa, Greece Stefano Chiarandini, Trieste, Italy Albert Kota, Vellore, India Michele Antonello, Padua, Italy William Jordan, Atlanta, USA Ian Spark, Adelaide, Australia Khamin Chinsakchai, Bangkok, Thailand Drosos Kotelis, Aachen, Germany Frank Arko, Charlotte, USA Lowell Kabnick, New York, USA Marlon Spreen, Amsterdam, Netherlands Che Lok Felix Chow, Hong Kong Ulrich Kugelmann, Gunzburg, Germany Jennifer Ash, Champaign, USA Andrea Kahlberg, Mila, Italy Benjamin Starnes, Seattle, USA Joannis Constantinides, London, UK Gaetano La Barbera, Palermo, Italy Mollie Atherton Meek, Little Rock, USA John Kakisis, Athens, Greece Martin Takes, Basel, Switzerland Ricardo Costantini, Pilar, Argentina Paul Lajos, New York, USA Efthymios Avgerinos, Pittsburgh, USA Evi Kalodiki, London, UK Hong-Yau Tan, Bedford Park, Australia Alexander Coupland, London, UK María Pilar Lamarca Mendoza, Toledo, Spain Martin Banyai, Zurich, Switzerland Barry Katzen, Miami, USA Ulf Teichgraeber, Jena, Germany Beatrix Cucuruz, Nürnberg, Germany Alexander Lamprou, Drachten, Netherlands Iris Baumgartner, Bern, Switzerland Neil Khilnani, New York, USA Gunnar Tepe, Rosenheim, Germany Jorge Cuenca, Granada, Spain Chawakorn Leampriboon, Muang, Thailand Joseph Bavaria, Philadelphia, USA David Kingsmore, Glasglow, UK Fabien Thaveau, Strasbourg, France Michael Cumming, St Louis Park, USA Regent Lee, Headington, UK Jean-Pierre Becquemin, Champigny-sur-Marne, France Angela Kokkosis, Dix Hills, USA David Thompson, Manchester, UK Lizzie Curry, Stoke-on-Trent, UK Vaibhav Lende, Bangalore, India Luca Bertoglio, Milan, Italy Tilo Kölbel, Hamburg, Germany Giovanni Torsello, Münster, Germany Gary Andrew Cuthbert, Leeds, UK Marco Leopardi, L’Aquila, Italy Colin Bicknell, London, UK Raghu Kolluri, Columbus, USA Matteo Tozzi, Varese, Italy Robert Damstra, Drachten, Netherlands Mimi Li, London, UK Martin Björck, Uppsala, Sweden Ahmed Koshty, Siegen, Germany Magdiel Trinidad Vazquez, Guadalajara, Mexico Katy Darvall, Taunton, UK Yin Ting Liau, Singapore Patrick Björkman, Helsinki, Finland Dainis Krievins, Riga, Latvia Miriam Elizabeth Uhlmann, Wien, Austria Saroj Das, Uxbridge, UK Chung-sim Lim, London, UK Stephen Black, London, UK Christopher Lattimer, Southall, UK Sari Vahaaho, Espoo, Finland Huw Davies, Birmingham, UK Yi Ting Lim, Singapore Jan Blankensteijn, Amsterdam, Netherlands Jeffrey Lawson, Durham, USA Domenico Valenti, London, UK Dharmeshkumar Davra, Bangalore, India Hans I.V. Lindgren, Helsingborg, Sweden Dittmar Böckler, Heidelberg, Germany Bertrand Le Halle, Essey-lès-Nancy, France Joost van Herwaarden, Utrecht, Netherlands Sophie de Gier, Doetinchem, Netherlands Pravin Lingam, Singapore, Laurence Boon, Brussels, Belgium Sandro Lepidi, Padova, Italy Marie Josee Van Rijn, Rotterdam, Netherlands Rick de Graaf, Maastricht, Netherlands Zhiwen Joseph Lo, Singapore Marc Bosiers, Dendermonde, Belgium Michael Lichtenberg, Arnsberg, Germany Frank Veith, New York, USA Sylvana de Mik, Amsterdam, Netherlands Chiara Lomazzi, San Donato Milanese, Italy Kursat Bozkurt, Istanbul, Turkey Francesco Liistro, Arezzo, Italy Maarit Venermo, Helsinki, Finland Brahman Dharmarajah, London, UK Cristina Lozano Ruiz, Albacete, Spain Andrew Bradbury, Birmingham, UK Jes Lindholt, Viborg, Denmark Hence Verhagen, Rotterdam, Netherlands Karen Dhillon, London, UK Pierleone Lucatelli, Rome, Italy Marianne Brodmann, Graz, Austria Romaric Loffroy, Dijon Cedex, France Eric Verhoeven, Nuremberg, Germany Jasmin Dillner, Magdeburg, Germany Marzia Lugli, Modena, Italy Jocelyn Brookes, London, UK Ian Loftus, London, UK Frank Vermassen, Ghent, Belgium Mario D’Oria, Trieste, Italy Oliver Lyons, London, UK Elchanan Bruckheimer, Petach Tikva, Israel Lars Lönn, Copenhagen, Denmark Fabio Verzini, Perugia, Italy Dirk Dreyer, Wangs, Switzerland Xiaohui Ma, Beijing, China Jan Brunkwall, Cologne, Germany Alan Lumsden, Houston, USA Thomas Vesely, Saint Louis, USA Mark Earle, St. John’s, Canada Payman Majd, Cologne, Germany Jacob Budtz-Lilly, Uppsala, Sweden Sean Lyden, Cleveland, USA Renu Virmani, Gaithersburg, USA Salma El Batti, Paris, France Marek Majewski, Suresnes, France Jacques Busquet, Paris St Cloud, France Lindsay Machan, Vancouver, Canada Harry Voesten, Drachten, Netherlands Maxime Elens, Brussels, Belgium Alban Malaj, Rome, Italy Caroline Caradu, Bordeaux, France Vladimir Makaloski, Hamburg, Germany Robert Vogelzang, Chicago, USA Mohammed Elkassaby, Galway, Ireland Mahmoud Malas, Baltimore, USA Yiu Che Chan, Hong Kong Thomas Maldonado, New York, USA Mark Vrancken Peeters, Nijmegen, Netherlands Mary Ellis, London, UK Sahar Mansour, London, UK Timothy Clark, Philadelphia, USA Martin Malina, London, UK Anders Wanhainen, Uppsala, Sweden Mohamed Elsharkawi, Galway, Ireland Clement Marcelin, Bordeaux, France Trevor Cleveland, Sheffield, UK Alexandros Mallios, Paris, France Rodney White, Torrance, USA Mohamed Elsherif, Galway, Ireland Massimiliano Marrocco-Trischitta, San Donato Milanese, Italy Raphael Coscas, Boulogne-Billancourt, France Kevin Mani, Uppsala, Sweden Walter Wohlgemuth, Regensburg, Germany Stefan Engelhard, The Hague, Netherlands Ombretta Martinelli, Rome, Italy Frank Criado, Baltimore, USA Hugh Markus, Cambridge, UK Nick Wojtaszek, Warsaw, Poland Florian Enzmann, Salzburg, Austria Claudia Martinez, Dublin, Ireland Martin Czerny, Freiburg, Germany Guy Martin, London, UK Thomas Wyss, Bern, Switzerland Joshua Kenneth Eves, Hull, UK Isaac Martínez, Madrid, Spain Michael Dake, Stanford, USA Chiara Mascoli, Bologna, Italy Wayne Yakes, Englewood, USA Leonie Fassaert, Utrecht, Netherlands Francis Matthey, London, UK Clement Darling, Albany, USA Tara Mastracci, London, UK Kakkhee Yeung, Amsterdam, Netherlands Carlota Fernandez Prendes, Oviedo, Spain Carlo Maturi, Padova, Italy Alun Davies, London, UK Ian McCafferty, Birmingham, UK Yoshihiko Yokoi, Tokyo, Japan Luis Mariano Ferreira, Buenos Aires, Argentina Daniela Mazzaccaro, San Donato Milanese, Italy Gert Jan de Borst, Utrecht, Netherlands Charles McCollum, Manchester, UK Thomas Zeller, Bad Krozingen, Germany Maria Jose Ferreira Barbas, Lisbon, Portugal David McLain, Llantarnam, UK Jean-Paul de Vries, Nieuwegein, Netherlands Richard McWilliams, Liverpool, UK Maciej Zielinski, Poznan, Poland Alexander Flor, Vienna, Austria Guilherme Meirelles, Campinas, Brazil Sebastian Debus, Hamburg, Germany Mark Meissner, Seattle, USA Rachael Forsythe, Edinburgh, UK Associate Faculty Mariagnese Mele, Siena, Italy Koen Deloose, Dendermonde, Belgium Matthew Menard, Boston, USA Mazin Foteh, Austin, USA Asser Abd El-Hamid Goda, Cairo, Egypt Robert Mendes, Lillington, USA Celine Deslarzes-Dubuis, Lausanne, Switzerland Christopher Metzger, Kingsport, USA Claude Franceschi, Paris, France Mohamed Abdelmaksoud, Hessen, Germany Gaspar Mestres, Barcelona, Spain Young Soo Do, Seoul, South Korea Bruno Migliara, Peschiera, Italy Marco Franchin, Varese, Italy Mohammed Abdulrasak, Kristianstad, Sweden Matthew Metcalfe, Stevenage, UK Konstantinos Donas, Münster, Germany Ross Milner, Chicago, USA Alberto Froio, Monza, Italy Pierfilippo Acciarri, Ferrara, Italy Rene Milleret, Montpellier, France Walter Dorigo, Florence, Italy Hiren Mistry, London, UK Gregory Fulton, Wilton, Ireland Lawish Agarwal, Bangalore, India Matias Rafael Mon Noboa, La Plata, Argentina Bernhard Dorweiler, Mainz, Germany Kasuo Miyake, São Paulo, Brazil Raghvinder Gambhir, Chessington, UK Pekka Aho, Helsinki, Finland Hayley Moore, London, UK Eric Ducasse, Bordeaux, France Bijan Modarai, London, UK Roberto Gandini, Rome, Italy Mustafa Akbulut, Istanbul, Turkey Kiyofumi Morishita, Hakodate, Japan Matthew Eagleton, Cleveland, USA Frans Moll, Utrecht, Netherlands Lianne Garbutt, London, UK Julien Al Shakarchi, Halesowen, UK Peter Mortimer, London, UK Hans-Henning Eckstein, Munich, Germany Robert Morgan, London, UK Margaret Gardner, Ashtead, UK Erasto Aldrett Lee, San Luis Potosi, Mexico Kieran Murphy, Toronto, Canada Michael Edmonds, London, UK Erin Murphy, Charlotte, USA Daniel Gil, Barcelona, Spain Ahmed Allam, Benha, Egypt Liam Musto, Maidstone, UK Steve Elias, Englewood, USA Jihad Mustapha, Grand Rapids, USA Agne Gimzauskaite, Kaunas, Lithuania Faris Alomran, Paris, France Piotr Myrcha, Warsaw, Poland David Epstein, York, UK Patrice Mwipatay, Perth, Australia Rocco Giudice, Rome, Italy Christiana Anastasiadou, Pefki, Greece Ahmed Naga, Alexandria, Egypt Mohammad Eslami, Pittsburgh, USA Spyridon Mylonas, Cologne, Germany Jerzy Glowinski, Bialystok, Poland Konstantin Andreychuk, St Petersburg, Russia Sriram Narayanan, Singapore Fabrizio Fanelli, Florence, Italy Evi Nagler, Ghent, Belgium Jan Peter Goltz, Lübeck, Germany Wei-Wen Ang, Singapore Achim Neufang, Weisbaden, Germany Melanie Field, Birmingham, UK Ross Naylor, Leicester, UK Gabriela Gonçalves Martins, Barcelona, Spain Susanne Anton, Lübeck, Germany Pasha Normahani, London, UK Katie Fielding, Derby, UK Oskar Nelzen, Linköping, Sweden Steve Goodyear, Worcester, UK Christos Argyriou, Alexandroupolis, Greece Katariina Noronen, Helsinki, Finland Martin Fox, Manchester, UK Richard Neville, Annandale, USA Prakash Goura, Trivandrum, India Jesus Emmanuel Arriaga-Caballero, Mexico Stefan Ockert, Lucerne, Switzerland Ian Franklin, London, UK Andrew Nicolaides, London, UK Marcelo Grill, São Paulo, Brazil City, Mexico Altino Ono Morais, São Paulo, Brazil Peter Gaines, Sheffield, UK Gustavo Oderich, Rochester, USA Tomasz Grzela, Bydgoszcz, Poland Anastasia Artemova, St Petersburg, Russia Niall O’Reilly, Waterford, Ireland Mauro Gargiulo, Bologna, Italy Hidemitsu Ogino, Kamakura, Japan Samit Gupta, Menlo Park, USA Simon Ashley, Plymouth, UK Viktor Orias, Budapest, Hungary Sergio Gianesini, Ferrara, Italy Tanya Oswald, Miami, USA Adam Gwozdz, London, UK Afshin Assadian, Wien, Austria David Ormesher, Manchester, UK Paul Gibbs, Portsmouth, UK Ashish Patel, London, UK Shahab Hajibandeh, Salford, UK Bilal Azhar, London, UK Evren Özçinar, Ankara, Turkey Kathleen Gibson, Bellevue, USA Michele Piazza, Padova, Italy Claudine Hamel-Desnos, Caen, France Nobuyosh Azuma, Asahikawa, Japan Vinit Paliwal, Gurgaon, India James Gilbert, Oxford, UK Neil Piller, Adelaide, Australia Hj Hammawa, Coventry, UK Mustapha Azzam, London, UK Sam Pashneh-Tala, Sheffield, UK Petrut Gogalniceanu, London, UK Keith Poskitt, Cheltenham, UK Charmaine Harrison, Hampshire, UK Tibor Balazs, Bratislava, Slovakia P.M.T. Pattynama, Gouda, Netherlands Manj Gohel, Cambridge, UK Janet Powell, London, UK Thomas Heller, Rostock, Germany Irina Baimatova, Auckland, New Zealand Javier Peinado Cebrián, Toledo, Spain Alejandro Gonzalez Ochoa, San Luis, Mexico Giovanni Pratesi, Rome, Italy Kornelia Hirsch, Vienna, Austria Mohammad Esmaeil Barbati, Aachen, Germany Paolo Perini, Parma, Italy Yann Goueffic, Nantes, France Vaclav Prochazka, Ostrava, Czech Republic Wolfgang Hofmann, Feldkirch, Austria David Barilla, Messina, Italy John Pigott, Toledo, USA Peter Goverde, Antwerp, Belgium Krzysztof Pyra, Warsaw, Poland Wen Hsien Hsu, Taipei, Taiwan Ivan Barna, Kiev, Ukraine Paul Pittaluga, Monaco William Gray, Wynnewood, USA Dheeraj Rajan, Toronto, Canada Ulrike Huegel, Bern, Switzerland Gareth Bate, Solihull, UK Irina Popova, Novosibirsk, Russia Stephen Greenhalgh, London, UK Ravi Rajani, Atlanta, USA Eline Huizing, Beverwijk, Netherlands Fernando Belcastro, Buenos Aires, Argentina Anna Prent, London, UK Roger Greenhalgh, London, UK Barbara Rantner, Innsbruck, Austria Rajesh Hydrabadi, Ahmedabad, India Iannis Ben Abdallah, Paris, France Rebecca Preston, Leeds, UK Franco Grego, Padua, Italy Simon Redwood, London, UK Pavel Ignatenko, Novosibirsk, Russia Filippo Benedetto, Messina, Italy Nattawut Puangpunngam, Bangkok, Thailand Matthew Joe Grima, London, UK Michel Reijnen, Arnhem, Netherlands Reza Indrakusuma, Amsterdam, Netherlands Ruth Benson, Birmingham, UK Nadeem Qazi, London, UK Wei Guo, Beijing, China Timothy Resch, Malmo, Sweden Mohamed Ismail, Cairo, Egypt Thoetphum Benyakorn, Phatumthani, Thailand Abul Quddus, Stockport, UK Eric Hager, Pittsburgh, USA Robert Rhee, New York, USA Usman Jaffer, London, UK Patrick Berg, Kevelaer, Germany Samina Qureshi, London, UK Mo Hamady, London, UK Vincent Riambau, Barcelona, Spain Hamid Jalalzadeh, Amsterdam, Netherlands Christian Bianchi, Loma Linda, USA Johann Christoph Ragg, Berlin, Germany Vanessa Harvey, London, UK Jean-Baptiste Ricco, Poitiers, France Marloes Jansen, Utrecht, Netherlands Aurélia Bianchini, Valenciennes, France Zoran Rancic, Zurich, Switzerland Baderkhan Hassan, Uppsala, Sweden Randolph C Robinson, Denver, USA Arkadiusz Jawien, Bydgoszcz, Poland Roberto Bisceglie, Rome, Italy Hema Rao, London, UK Stéphan Haulon, Le Plessis-Robinson, France Krishna Rocha Singh, Springfield, USA Jérémie Jayet, Boulogne-Billancourt, France Pavel Bondarenko, St Petersburg, Russia John Rasmussen, Houston, USA Paul Hayes, Cambridge, UK Enric Roche, Sant Cugat del Valles, Spain Qizhuang Jin, Beijing, China Rodrigo Bono Fukushima, São Paulo, Brazil Sudip Ray, London, UK Francine Heatley, London, UK Fiona Rohlffs, Hamburg, Germany Maki Jitsumura, Wrexham, UK Roshan Bootun, London, UK Mahmood Razavi, Orange, USA Ulf Hedin, Stockholm, Sweden Melvin Rosenblatt, Fairfield, USA Pablo Justo Avila, Derby, UK Denis Borsuk, Chelyabinsk, Russia Ernö Remsey-Semmelweis, Marburg, Germany Franziska Heidemann, Hamburg, Germany Kenneth Rosenfield, Boston, USA Maciej Juszczak, Oxford, UK Alessio Bozzi, Benevento, Italy Mohamed Rizk, Cairo, Egypt Ivika Heinola, Helsinki, Finland Fabio Rossi, São Paulo, Brazil Kyriaki Kakavia, Athens, Greece A.R.T. Brand, Utrecht, Netherlands Steven Rogers, Manchester, UK Jan Heyligers, Tilburg, Netherlands Maria Antonella Ruffino, Turin, Italy Adel Kamhawy, Tanta, Egypt Vincenzo Brizzi, Bordeaux, France Dmitry Rosukhovski, St Petersburg, Russia Robert Hinchliffe, Bristol, UK Bartosz Rylski, Freiburg, Germany Eleonora Karthaus, Leiden, Netherlands Alina-Maria Budacan, Birmingham, UK Umar Sadat, Cambridge, UK Tobias Hirsch, Halle, Germany Bertrand Saint-Lebes, Toulouse, France Nikolaos Karydis, London, UK James Budge, London, UK Prakash Saha, London, UK Andrew Holden, Auckland, New Zealand Timur Sarac, New Haven, USA Piotr Kaszczewski, Warsaw, Poland Sara Busto Suárez, Oviedo, Spain Enrique María San Norberto García, Valladolid, Nelson Hopkins, Buffalo, USA Dierk Scheinert, Leipzig, Germany Kemal Kemal, Nottingham, UK Tommaso Cambiaghi, Milan, Italy Spain Dominic Howard, Oxford, UK Bruno Scheller, Homburg, Germany Monta Kevina, London, UK Patrick Canning, Oranmore, Ireland Gautamn Sarwal, Vancouver, Canada Jeffrey Hull, North Chesterfield, USA Marc Schermerhorn, Boston, USA Panagiotis Kitrou, Patras, Greece Pedro José Carvalho Pinto Sousa, Coimbra, Tamer Sayed, Hove, UK Osamu Iida, Hyogo, Japan Oliver Schlager, Vienna, Austria Sanne Klaphake, Rotterdam, Netherlands Portugal Sofie Schmid, Munich, Germany Nicholas Inston, Birmingham, UK Andrej Schmidt, Leipzig, Germany Artis Knapsis, Düsseldorf, Germany Mariano Castelli, Buenos Aires, Argentina Arne Schwindt, Münster, Germany

2 Vascular & Endovascular Controversies Update 24–27 April 2018

Faculty CX Programme Organising Board John Scurr, London, UK Eva Sevick, Houston, USA Chairman Stroke from Thoracic Venous Julien Sfeir, Beirut, Lebanon Giada Sgorlon, Trieste, Italy Roger Greenhalgh Endovascular Procedures Joseph Shalhoub, London, UK Ian Franklin Emeritus Professor of Surgery and Head (STEP) Gennadii Sheiko, Nizhniy Novgorod, Russia Consultant Vascular Surgeon at London of Vascular Surgery Research Group at Vascular Clinic, London, UK Surendra Shenoy, St. Louis, USA Imperial College London, London, UK Stéphan Haulon Amanda Shepherd, London, UK Professor of Vascular Surgery, Université Pitchai Shivanesan, Thiruvananthapuram, India Paris Sud, Hôpital Marie Lannelongue, Le Stephen Black Ravinder Singh-Ranger, Swindon, UK Co-chairmen Plessis Robinson, France Consultant Vascular Surgeon at Guy’s Mosaad Soliman, Mansoura, Egypt and St Thomas’ Hospital, London, UK Joel Sousa, Oporto, Portugal Frans Moll Tilo Kölbel Giovanni Spinella, Genova, Italy Emeritus Professor of Vascular Surgery Alun Davies Domenico Spinelli, Messina, Italy Professor of Vascular Surgery, University at University Medical Center Utrecht, And Late-Breaking Venous Trials Robert Staffa, Brno, Czech Republic Utrecht, Netherlands of Hamburg, and Vascular Surgeon at Gerry Stansby, Newcastle-upon-Tyne, UK the University Heart Center Hamburg, Professor of Vascular Surgery at Imperial Ondrej Stehno, Harrow, UK Hamburg, Germany College London and Consultant General Stéphan Haulon Surgeon at Charing Cross Hospital, Tobias Steinke, Düsseldorf, Germany Professor of Vascular Surgery, Université London, UK Kate Stenson, London, UK Paris Sud, Hôpital Marie Lannelongue, Le Peripheral Arterial Francesco Stilo, Rome, Italy Plessis Robinson, France Peter Subramaniam, Adelaide, Australia Acute Stroke Cezary Szary, Warsaw, Poland Thomas Zeller Andrew Holden Professor of Angiology at Albert-Ludwigs Malgorzata Szostek, Warsaw, Poland Ross Naylor Kim Taeymans, Edegem, Belgium Associate Professor of Radiology at University of Freiburg and Head of Gergana Taneva, Münster, Spain Auckland University School of Medicine Department of Angiology at Universitäts Honorary Professor of Vascular Surgery and Director of Interventional Services at – Herzzentrum Freiburg, Bad Krozingen, at University of Leicester and Consultant Kullacha Taruetiyaputranon, Songkhla, Thailand Auckland City Hospital, Auckland, New Vascular Surgeon at Leicester Royal Matthew Thomas, Durham, UK Germany Zealand Infirmary, Leicester, UK John Thompson, Exeter, UK José Tiago, Loures, Portugal Giovanni Torsello Hugh Markus Matthias Trenner, Munich, Germany Aortic Emeritus Professor, Department of Rosario Tringale, Catania, Italy Vascular Surgery at Franziskus Hospital Professor of Stroke Medicine, Honorary Consultant Neurologist, University of Viktoriya Tsay, Tashkent, Uzbekistan Dittmar Böckler and Director of the Clinic for Vascular and Salvatore Alberto Turiano, Catania, Italy Endovascular Surgery at the University of Cambridge, Cambridge, UK Professor of Vascular Surgery at Jean-Francois Uhl, Paris, France Münster, Münster, Germany University of Heidelberg and Head of Daniel Urriza Rodriguez, Ducklington, UK Department of Vascular Surgery and Vascular Access Münster, Germany Iris Baumgartner Marco Virgilio Usai, Endovascular Surgery at University Suvi Vaaramaki, Tampere, Finland Professor and Head of Clinical and Hospital Heidelberg, Heidelberg, Nicholas Inston Theodorus van Bakel, Ann Arbor, USA Germany Interventional Angiology and Director of Marijn van den Houten, Eindhoven, Netherlands Vascular Research at University Hospital Consultant Surgeon and Clinical Lead Bern, Bern, Switzerland for Renal Surgery and Transplantation at Steven van Haelst, Utrecht, Netherlands Giovanni Torsello Constance van Laarhoven, Utrecht, Netherlands Queen Elizabeth Hospital Birmingham, Emeritus Professor, Department of Birmingham, UK Karen van Langenhove, Ghent, Belgium Trevor Cleveland Vascular Surgery at Franziskus Hospital Nick S. van Reijen, Amsterdam, Netherlands and Director of the Clinic for Vascular and Consultant Vascular Radiologist and Pierfrancesco Veroux, Catania, Italy Domenico Valenti Endovascular Surgery at the University of Honorary Senior Lecturer at Sheffield Juha Virtanen, Turku, Finland Münster, Münster, Germany Teaching Hospitals NHS Foundation Trust, Consultant Vascular Surgeon and Olexondr Voloshyn, Zaporozhye, Ukraine Sheffield, UK and President of BSIR Honorary Senior Lecturer at King’s Bianca Vriens, Colchester, UK College London, London, UK Tilo Kölbel Arno Wiersema, Amsterdam, Netherlands Cliff Shearman Andrew Wigham, Oxford, UK Professor of Vascular Surgery, University Emeritus Professor of Vascular Surgery at Congenital Vascular Angela Williams, London, UK of Hamburg, and Vascular Surgeon at the University Heart Center Hamburg, University of Southampton and Vascular Masato Yamaguchi, Kobe, Japan Malformations Hamburg, Germany Surgeon in the Department of Vascular Dean Yamaguchi, Greenville, USA Surgery, University Hospital Southampton Ramesh Yap Kannan, Leicester, UK Krassi Ivancev (Chairman) Frank Vermassen Foundation Trust, Southampton, UK Nam Yeul Yim, Gwangju, South Korea Consultant within the field of vascular Abdurasul Yulbarisov, Tashkent, Uzbekistan Professor in Vascular and Thoracic Frank Vermassen malformations treatment at the Gladiol Zenunaj, Ferrara, Italy Surgery Department of Vascular Surgery Department of Vascular Medicine, Professor in Vascular and Thoracic Sebastian Zerwes, Augsburg, Germany at Ghent University Hospital, Ghent, University Hospital Hamburg-Eppendorf, Surgery Department of Vascular Surgery Yuehong Zheng, Beijing, China Belgium Hamburg, Germany; Honorary Professor, at Ghent University Hospital, Ghent, Aleksandra Charlotte Zoethout, Groningen, Division of Surgery & Interventional Belgium Netherlands Sciences, Faculty of Medical Sciences, Ekaterina Zvereva, St Petersburg, Russia Late-Breaking Aortic Trials University College London, London, UK Ewa Zywicka, Aylesbury, UK Janet Powell Diabetic and Wound Care Fiona Rohlffs Department of Vascular Medicine, Industry Speakers Professor of Vascular Biology and University Hospital Hamburg-Eppendorf, Stephen Barker, Shirley, USA Medicine, Imperial College London, Michael Edmonds Hamburg, Germany, London, UK Davean Chopra, Santa Rosa, USA Professor of Diabetic Foot Medicine Alan Edwards, Ruthin, UK and Consultant Diabetologist at King’s Jeffrey Jump, Mont-sur-Rolle, Switzerland College Hospital, London, UK Next-Generation Vascular Gido Karges, Wangs, Switzerland Specialists Bob Mitchell, Irvine, USA Julian Rieck, Speyer, Germany International Advisors CX Abstract and Poster Board Robert Hinchliffe Dan Rose, Paris, France Patrick Peeters Eric Chemla Malcolm Ian Loftus Robert Rachel Bell Clinical Professor of Vascular Surgery Chas Taylor, Horsham, UK Eric Verhoeven Matt Thompson Simms Meryl Davis Hinchliffe Marcus Brooks at University of Bristol and Vascular Erik Vollebregt, Amsterdam, Netherlands Surgeon at North Bristol NHS Trust, Gunnar Tepe George Richard Gibbs Colin Bicknell Simon Ashley Bristol, UK Jan Brunkwall Hamilton Daryll Baker Anna Prent

Celebrate 40 Years of Looking Forward NEW this year! CX is hosting a “40 Years of Looking Forward” • More hands-on party (7–11.30pm) on Thursday 26th April 2018 opportunities with at one of London’s most unique venues, the the CX Peripheral Science Museum. The party will be held—in and Aortic keeping with CX’s forward-looking approach—in Workshops the Making the Modern World gallery. • CX Global Stars For details, see: www.cxsymposium.com/40-years-looking-forward and Rising Stars • Late-breaking trials

3 Years of Looking Forward - Plenary Programme

Dear colleague

This year represents CX’s 40th Year of Looking Forward and marks the start of a new cycle of Controversies, Challenges, and Consensus. CX 2018, therefore, will focus on Controversies in all aspects of vascular disease management. Highlights of the meeting include:

Three days of Peripheral Ischaemia Controversies Three days of Abdominal Aortic Controversies • Peripheral Proximal Arterial Ischaemia Controversies, with debates • CX debate on mycotic aneurysm—in a fit patient, the first choice is focusing on topics such as the evidence for and against an “endo for open surgery (for/against) first” approach vs. a surgical approach • EVAR in women controversies • Late-breaking trials and first-on-podium presentations • Late-breaking aortic trials • 2017 ESC/ESVS guidelines on peripheral arterial disease • NEW! CX Aortic Workshop • Peripheral Critical Ischaemia Controversies, which is both a • CX Aortic Techniques & Technologies celebration of 10 years of ilegx and a collaboration with the Critical Limb Ischaemia Global Society Two days of Thoracic Aortic Controversies, • NEW! CX Peripheral Workshop including Juxta-renal (Complex Abdominal Aortic) Controversies • CX Peripheral Techniques & Technologies • Dissecting aneurysm controversies Three days of Venous Controversies • Radiation • A CX Debate on whether or not ATTRACT is the final word on lysis • controversies of proximal deep vein thrombosis • Podium 1st—Repair of complex TAAA • Venous ulcers and wound care • CX Great Debate on whether FEVAR is best for juxta-renal • Pelvic vein reflux aneurysm repair • Venous Techniques and Technologies • Stroke from Thoracic Endovascular Procedures (STEP) • CX Venous Workshop—now in its 10th year! One day of Acute Stroke Controversies • Carotid controversies • Cerebral and vertebral controversies

Roger Greenhalgh Chairman, CX Programme Organising Board

Register now! Early bird rates end at midnight on 25th February

CX at a glance 2018

Date/Location Upper Main Auditorium Lower Main Auditorium Learning Centre 1 Learning Centre 2 Learning Centre 3 Venous City Peripheral Village Aortic Village Vascular Access Village

CX Abdominal Aortic Global Stars & Rising CX Congenital Vascular Stars Malformations Peripheral Proximal Tuesday Arterial Ischaemia Venous Controversies 24 April Controversies CX Aortic Techniques & CX Abdominal Aortic Technologies Abstracts 08:00-18:00 Plenary Programme Plenary Programme CX Vascular Access Abstracts CX Abdominal Aortic Abstracts

CX Thoracic Aortic LINC@CX Global Stars & Rising Stars

CX Vascular Access CX Thoracic Aortic Wednesday Abdominal Aortic CX Venous Workshop CX Peripheral Masterclass Abstracts CX Aortic Workshop 25 April Controversies & Edited Cases Workshop 08:00-18:00 CX Peripheral CX Peripheral Arterial Plenary Programme Techniques & Global Stars & Rising Technologies Stars

CX Peripheral Arterial Abstracts

Thoracic Aortic CEC@CX Controversies CX Peripheral Arterial Abstracts Peripheral CX Vascular Access Plenary Programme Workshop Thursday Critical Ischaemia CX Venous Workshop CX Peripheral CX Innovation CX Aortic Workshop 26 April Controversies & Edited Cases Workshop Showcase 08:00-18:00 Juxta-renal (Complex CX Meets Latin America Abdominal Aortic) Plenary Programme Controversies CX Acute Stroke Global Plenary Programme Stars & Rising Stars and Abstracts

CX Venous Global Stars Acute Stroke & Rising Stars Friday Controversies 27 April EVST Prize Session 08:00-13:00 Plenary Programme CX Venous Abstracts

Plenary topics key

These colour-coded boxes help you identify your topics of interest

■ Aortic ■ Acute Stroke ■ Peripheral Arterial ■ Venous

4 Vascular & Endovascular Controversies Update 24–27 April 2018

Tuesday 24 April 2018

Audience participation and discussion PERIPHERAL PROXIMAL ARTERIAL ISCHAEMIA CONTROVERSIES LUNCH Industry Sponsored Satellite Upper Main Auditorium See more on page 21

Medical management, diagnosis and decision-making Drug-coated balloons IN.PACT DCB vs. PTA four-year data Peter Schneider, Honolulu, United States Contemporary medical therapy of patients with intermittent claudication and critical limb ischaemia Iris Baumgartner, Bern, Switzerland Long Lutonix lesions—24-month outcomes Martin Banyai, Luzern, Switzerland What ABPI and TBPI tells us about the prognosis and how clopidogrel and Audience participation and discussion statins impact it Maarit Venermo, Helsinki, Finland Podium 1st: Independently adjudicated prospective randomised controlled Audience participation and discussion trial of DCB vs. PTA in restenotic non-stented SFA lesions at two years Osamu Iida, Hyogo, Japan Severe aortic bifurcation and iliac occlusive arterial DES vs. DEB—DRASTICO trial Francisco Liistro, Arezzo, Italy Podium 1st: Effectiveness of paclitaxel-coated balloon catheter vs. disease uncoated balloon-coated catheter in the SFA. PA to prevent restenosis or reocclusion—12-month data Ulf Teichgräber, Jena, Germany WHETHER to intervene, WHEN to INTERVENE, ILLUMENATE study Marianne Brodmann, Vienna, Austria INTERVENTION METHOD AND FOLLOW-UP Sirolimus-eluting DCB for femoropopliteal lesions—the SELUTION trial Covered endovascular reconstruction of the aortic bifurcation (CERAB) Thomas Zeller, Bad Krozingen, Germany Peter Goverde, Antwerp, Belgium The ENDURE study outcomes and an update on the Chocolate Touch Endovascular vs. open treatment of severe aortoiliac occlusive disease— randomised controlled trial Gunnar Tepe, Bad Rosenheim, Germany outcomes of kissing self-expanding covered stent for reconstruction of the Audience participation and discussion aortic bifurcation Sandro Lepidi, Padua, Italy Two-year outcomes of complex iliac arterial disease with a balloon Stents, drug-eluting stents and bioabsorbable expandable stent trial Christopher Metzger, Kingsport, United States Audience participation and discussion scaffolds Sirolimus bioresorbable scaffold—an update on the DESappear trial Andrew Holden, Auckland, New Zealand Endo first vs. open surgery—the evidence The potential value of swirling flow—the BioMimics study programme CX Debate: Common femoral and profunda femoris artery disease are best Peter Gaines, Sheffield, United Kingdom managed by open surgery Audience participation and discussion Cliff Shearman, Southampton, United Kingdom For the motion: Against the motion: Yann Goueffic, Nantes, France TEA Audience participation, discussion and polling CX Great Debate: Endovascular first for critical limb ischaemia is a Access techniques and peri-interventional imaging concept without evidence Retrograde tibial access for failed antegrade superficial femoral artery For the motion: Andrew Bradbury, Birmingham, United Kingdom recanalisation Fabrizio Fanelli, Florence, Italy Matthew Menard, Boston, United States Retrograde femoral access for failed antegrade superficial femoral artery— Clement Darling, Albany, United States recanalisation Andrej Schmidt, Leipzig, Germany Against the motion: Thomas Zeller, Bad Krozingen, Germany Andrew Holden, Auckland, New Zealand  The potential value of IVUS-guided superficial femoral artery Peter Schneider, Honolulu, United States interventions—a randomised trial TBA Audience participation, discussion and polling Vector velocity ultrasound—a new ultrasound technique Lars Lönn, Copenhagen, Denmark COFFEE Audience participation and discussion Industry Sponsored Satellite See more on page 21 Guidelines, recommendations and opinions European Society of Cardiology and European Society for Vascular Surgery Intermittent claudication and superficial femoral guidelines Jean-Baptiste Ricco, Poitiers, France artery Fabrizio Fanelli, Florence, Italy Endovascular vs. open surgery of superficial femoral artery disease— Audience participation and discussion ZILVERPASS trial Marc Bosiers, Dendermonde, Belgium CX Debate: Surgery is the only durable treatment option for in-stent Reconstruction of the superficial femoral artery by a dual component occlusion flexible stent Fabien Thaveau, Strasbourg, France For the motion: TBA Against the motion: Thomas Zeller, Bad Krozingen, Germany REAL PTX—DCB and BMS vs. Zilver PTX Dierk Scheinert, Leipzig, Germany Audience participation, discussion and polling SUPER B trial Michel Reijnen, Arnhem, Netherlands Limb salvage in acute ischaemia due to occlusion of popliteal aneurysm Audience participation and discussion Thomas Wyss, Bern, Switzerland The cost of emergency peripheral events for the patient and the health Emerging devices and interventional techniques service Dominic Howard, Oxford, United Kingdom Vessel preparation devices Audience participation and discussion Treating the superficial femoral artery with a serration balloon catheter Peter Schneider, Honolulu, United States CX Debate: Directional atherectomy pre-treatment and use of Chocolate Additional Peripheral Arterial activities will improve patency results of DCB For the motion: Thomas Zeller, Bad Krozingen, Germany Peripheral Critical Ischaemia Controversies Against the motion: Frans Moll, Utrecht, Netherlands Thursday 26 April Page 9 Audience participation, discussion and polling CX Peripheral Techniques & Technologies The place of atherectomy and DCB Michael Lichtenberg, Arnsberg, Germany Wednesday 25 April Page 14 The value of debulking first in peripheral arterial disease LINC@CX Martin Takes, Basel, Switzerland Wednesday 25 April Page 15 Audience participation and discussion Peripheral Arterial Abstracts Page 17 Late-breaking trials and first-on-podium presentations BATTLE: Randomised controlled trial at one year—paclitaxel-eluting stent vs. bare metal stent Yann Goueffic, Nantes, France BIOLUX P-III Gunnar Tepe, Bad Rosenheim, Germany

This preliminary CX Programme is subject to change

5 Years of Looking Forward - Plenary Programme

Tuesday 24 April 2018

VENOUS CONTROVERSIES Pelvic vein reflux Lower Main Auditorium WHETHER to intervene, WHEN to intervene, HOW to intervene WHETHER to intervene, WHEN to intervene, HOW to CEAP for pelvic vein disorder Mark Meissner, Seattle, United Kingdom intervene: Outcomes and Follow-up Define the pelvic venous congestion symptom and intervention Mel Rosenblatt, Fairview, United States Imaging section and diagnostics controversies Development in evidence base for pelvic vein disorders Neil Khilnani, New York, United States The future of venous imaging TBA Trial on correction of venous reflux via internal jugular vein Haemodynamics—objective assessment of venous and lymphatic function David Thompson, Manchester, United Kingdom Sergio Gianesini, Ferrara, Italy Audience participation and discussion Strain gauge plethysmography Oskar Nelzen, Linköping, Sweden TEA Audience participation and discussion

Deep venous controversies Superficial venous Sclerotherapy for pudendal thigh veins Kathleen Gibson, Bellevue, United States Acute Deep Venous Thrombosis Evidence for cyanoacrylatic ablation Kursat Bozkurt, Istanbul, Turkey Deep vein thrombosis and pregnancy TBA One extra drop made a difference in closure rate for endovenous Long-term outcomes of indwelling vena cava filters cyanoacrylate treated great saphenous vein ≥8mm in diameter Eric Hager, Pittsburgh, United States Yiu Che Chan, Hong Kong Purely mechanical thrombectomy in acute deep vein thrombosis—a The pitfalls of endovenous cyanoacrylate Tobias Hirsch, Halle, Germany multicentre retrospective analysis Romaric Loffroy, Dijon, France The current status of endothermal ablation Jose Almeida, Miami, United States CX DEBATE: ATTRACT is the final word on lysis of proximal deep vein thrombosis Mechanochemical ablation—the current status For the motion: TBA Steve Elias, Englewood, United States Against the motion: Mitchell Silver, Columbus, United States Retrospective review of complications in 577 consecutive cases of cryo- Audience participation, discussion and polling laser and cryo-sclerotherapy guided by augmented reality Kasuo Miyake, São Paulo, Brazil COFFEE Reducing the incidence of hyperpigmentation after sclerotherapy with the Industry Sponsored Satellite use of an antithrombotic drug Alejandro Gonzalez Ochoa, San Luis, Mexico See more on page 21 Photodocumentation in aesthetic phlebology Kasuo Miyake, São Paulo, Brazil Venous stent Audience participation and discussion Entrapment and nutcracker syndrome Alun Davies, Imperial College, London, United Kingdom Risk of venous stenting across the inguinal ligament on occlusion of great Additional Venous activities saphenous vein Houman Jalaie, Aachen, Germany CX Venous Workshop Analysis of morphology after stenting Michael Lichtenberg, Arnsberg, Germany Wednesday 25 April and Thursday 26 April Page 11 Link between morphology of iliac veins and outcomes Lowell Kabnick, New York, United States CX Venous Techniques & Technologies The rationale for the ABRE venous stent design Wednesday 25 April and Thursday 26 April Page 11 Erin Murphy, Charlotte, United States Venous Abstracts Page 19 VERNACULAR trial - Venovo venous stent Jose Almeida, Miami, United States The need for a venous valve Mark Meissner, Seattle, United States Audience participation and discussion

Venous ulcers and wound care Value of nurse specialists for venous ulcer management Vanessa Harvey, London, United Kingdom The treatment of venous ulcers following ESCHAR Keith Poskitt, Cheltenham, United Kingdom The EVRA trial Manj Gohel, Cambridge, United Kingdom Francine Heatley, Imperial College, London, United Kingdom Alun Davies, Imperial College, London, United Kingdom David Epstein, York, United Kingdom Ramifications of EVRA Raghu Kolluri, Columbus, United States Audience participation and discussion LUNCH Industry Sponsored Satellite See more on page 21

Lymphoedema Changing concepts of lymphatic function Neil Piller, Adelaide, Australia Hydrotherapy for lymphoedema Sergio Gianesini, Ferrara, Italy Surgical treatment of advanced lipoedema and lymphoedema Harry Voesten, Drachten, Netherlands Audience participation and discussion

This preliminary CX Programme is subject to change

6 Vascular & Endovascular Controversies Update 24–27 April 2018

Wednesday 25 April 2018

ABDOMINAL AORTIC CONTROVERSIES Late-breaking aortic trials EVAS is associated with a reduction in all-cause mortality Upper Main Auditorium Marc Schermerhorn, Boston, United States Impact of type IIIa and IIIb endoleaks in durability Screening and centralisation of services Stéphan Haulon, Le Plessis-Robinson, France Multi-year timeframe in the evaluation of durability of EVAR controversies Gustavo Oderich, Rochester, United States Screening for abdominal aortic aneurysm is cost-effective and a policy on Reintervention after EVAR on and off indications for use with risk-based 2.5–2.9cm aortic diameters Anders Wanhainen, Uppsala, Sweden modelling and Long-term Estimation Aortic Risk (LEAR) Evidence on patient volume, outcome and units of trading for EVAR and Ian Loftus, London, United Kingdom open repair Dittmar Böckler, Heidelberg, Germany EVAR 1, DREAM and OVER after 15 years The impact of centralisation and endovascular aneurysm repair on Jan Blankensteijn, Amsterdam, Netherlands treatment of ruptured abdominal aortic aneurysms based on international Five-year EVAR follow-up using repositioning and low type 1a endoleak registries Jacob Budtz-Lilly, Uppsala, Sweden rates Eric Verhoeven, Nuremberg, Germany Impact of centralisation and EVAR Kevin Mani, Uppsala, Sweden Ten-year EVAR follow-up vs. open repair with second-generation EVAR Generation of high-performance teams in emergency aortic surgery— Giovanni Pratesi, Rome, Italy simulated leadership and team training is effective TEA Colin Bicknell, Imperial College, London, United Kingdom Ruptured abdominal aortic aneurysm EVAR vs. open repair Hands-on in City and Villages Hidemitsu Ogino, Kamakura, Japan Prediction of less vigorous follow-up based upon the first postoperative CT Audience particpation and discussion scan Kevin Mani, Uppsala, Sweden Abdominal aortic aneurysm characteristics on tomographic ultrasound Outcome controversies which are associated with abdominal aortic aneurysm growth Charles McCollum, Manchester, United Kingdom CX Debate: In a fit patient, the first choice for is open surgery For the motion: Maarit Venermo, Helsinki, Finland A meta-analysis of the safety implications of non-compliance to Against the motion: Martin Malina, Copenhagen, Denmark endovascular aneurysm repair surveillance and the use of the Laxity Index Matthew Joe Grima, London, United Kingdom Audience participation, discussion and polling Follow-up after endovascular aneurysm repair can be stratified based on first postoperative imaging Baderkhan Hassan, Uppsala, Sweden EVAR in women controversies EVAR for octogenarians Patrice Mwipatayi, Perth, Australia Podium 1st: Risk of abdominal aortic aneurysm among male and female relatives of abdominal aortic aneurysm patients Follow-up modelling for clinical and cost-effectiveness of EVAR Hence Verhagen, Rotterdam, Netherlands Michael Sweeting, Cambridge, United Kingdom David Epstein, York, United Kingdom EVAR in women vs. men—early results of LUCY study Maarit Venermo, Helsinki, Finland Jennifer Ash, Champaign, United States Roger Greenhalgh, Imperial College, London, United Kingdom EVAR does not have worse outcomes in women Fiona Rohlffs, Hamburg, Germany Chiara Mascoli, Bologna, Italy Application of EndoAnchors in EVAR for short <10mm neck—rationale  ENGAGE—five years: Men /women Giovanni Pratesi, Rome, Italy for use, patient selection, sizing strategies, and technical appliation fo COFFEE technique Frank Arko, Charlotte, United States Industry Sponsored Satellite See more on page 21 Hands-on in City and Villages Additional Abdominal Aortic activities NEW! CX Aortic Workshop Internal iliac artery preservation controversies Wednesday 25 April and Thursday 26 April Page 14 Preservation of internal iliac artery blood flow in aneurysmal disease Jan Heyligers, Tilburg, Netherlands CX Aortic Techniques and Technologies Results of the pELVIS registry Giovanni Torsello, Münster, Germany Tuesday 24 April Page 15 Parallel graft use for internal iliac artery preservation Abdominal Aortic Abstracts Page 16 Vincent Riambau, Barcelona, Spain Audience participation and discussion

Results and follow-up of EVAR Device labelling is not always in the patient interest Tara Mastracci, London, United Kingdom Risk factors for iliac limb occlusion—one-year data with latest generation EVAR device Mauro Gargiulo, Bologna, Italy The AIDA study—a randomised multicentre three-armed clinical trial to prevent incisional hernia following abdominal aortic aneurysm open repair by onlay mesh augmentation Sebastian Debus, Hamburg, Germany Audience participation and discussion Mini-symposium on alternative access to control endoleaks controversies - transarterial Robert Morgan, London, United Kingdom Richard McWilliams, Liverpool, United Kingdom - translumbar Stéphan Haulon, Le Plessis-Robinson, France - transcaval Tilo Kölbel, Hamburg, Germany - para endograft Peter Schneider, Honolulu, United States - laparoscope Alan Lumsden, Houston, United States LUNCH Industry Sponsored Satellite See more on page 21 Hands-on in City and Villages

This preliminary CX Programme is subject to change

7 Years of Looking Forward - Plenary Programme

Thursday 26 April 2018 THORACIC AORTIC CONTROVERSIES Upper Main Auditorium

New thoracic aortic technologies STEP collaboration—roundtable presentations and New thoracic branched endoprosthesis for the aortic arch comments Dittmar Böckler, Heidelberg, Germany Presenters: Fiona Rohlffs; Stéphan Haulon, Tilo Kölbel and Hugh Markus, New descending thoracic aortic stent graft Frank Arko, Charlotte, United States Commentators: Michael Dake; Rodney White; Matthew Eagleton; Martin Czerny; Impact of left subclavian artery revascularisation on TEVAR Ahmed Koshty and Heniz Jakob Michael Dake, Stanford, United States Audience participation and discussion

Captivia France stenting of use of single aortic branch device TEA Hervé Rousseau, Toulouse, France Hands-on in City and Villages The new ascending stent graft Alan Lumsden, Houston, United States Giovanni Torsello, Münster, Germany The durability of low profile TEVAR Juxta-renal (complex abdominal aortic) controversies Podium 1st: Repair of complex TAAA Mini-symposium on controversies in management of short, angulated, wide Thomas Maldonado, New York, United States and challenging aortic proximal necks, chimney, FEVAR and open Endovascular repair in patients with connective tissue disorders—arch Eric Ducasse, Bordeaux, France Tilo Kölbel, Hamburg, Germany Dittmar Böckler, Heidelberg, Germany Endovascular repair in patients with connective tissue disorders—thoraco- Timothy Resch, Malmo, Sweden abdominal Gustavo Oderich, Rochester, United States Luca Bertoglio, Milan, Italy Stéphan Haulon, Le Plessis-Robinson, France Podium 1st: Endovascular custom Ovation review evidence for avoiding Endovascular repair in patients with connective tissue disorders—infrarenal FEVAR or parallel graft use Sean Lyden, Cleveland, United States Luca Bertoglio, Milan, Italy Endovascular first (FEVAR) to repair failed EVAR and the use of a bridging COFFEE stent Eric Verhoeven, Nuremberg, Germany Industry Sponsored Satellite Standard EVAR for wide necks Hence Verhagen, Rotterdam, Netherlands See more on page 21 Next generation conformable EVAR device with 90° angulated aortic neck Robert Rhee, New York, United States Hands-on in City and Villages The use of endoanchors for elective FEVAR Jean-Paul de Vries, Nieuwegein, Netherlands Dissecting aneurysm controversies Use of covered stents for visceral and aortoiliac injuries Remodelling of the thoracic aorta is favourable, but in the abdominal aorta it Maria Antonella Ruffino, Turin, Italy is not Kevin Mani, Uppsala, Sweden Prediction of long-term survival after FEVAR Siting matters when it comes to remodelling and false lumen thrombosis Bijan Modarai, London, United Kingdom following TEVAR in chronic type B dissection CX Great Debate: FEVAR is best for juxta-renal aneurysmal repair Frank Arko, Charlotte, United States For the motion: Bijan Modarai, London, United Kingdom Lessons to minimise procedural risks in type B dissection using a thoracic Gustavo Oderich, Rochester, United States endograft not using bare metal stent Bijan Modarai, London, United Kingdom Against the motion: Konstantinos Donas, Münster, Germany A new technique for treating type A dissection using a staged approach and Eric Ducasse, Bordeaux, France thoracic branched device Joseph Bavaria, Philadelphia, United States Additional Thoracic Aortic activities Radiation controversies Reduced radiation and choice of imaging modality for endoleak detection NEW! CX Aortic Workshop and correction Dittmar Böckler, Heidelberg, Germany Joost van Herwaarden, Utrecht, Netherlands Wednesday 25 April and Thursday 26 April Page 14 Stéphan Haulon, Le Plessis-Robinson, France Thoracic Abstracts Page 17 CX Great Debate: Traditional radiological positions on the right side of the patient are beneficial for radiation safety and offer superior work flow and access For the motion: Timothy Resch, Malmo, Sweden Tilo Kölbel, Hamburg, Germany Against the motion: Joost van Herwaarden, Utrecht, Netherlands Gustavo Oderich, Rochester, United States Deficiencies in operator behaviour—premature atypical malignancies in high-volume operators Bijan Modarai, London, United Kingdom Simulation helps operator radiation safety Lars Lönn, Copenhagen, Denmark LUNCH Industry Sponsored Satellite See more on page 21 Hands-on in City and Villages

Fenestrated aortic controversies French multicentre experience Raphael Coscas, Boulogne-Billancourt, France Jean-Pierre Becquemin, Champigny-sur-Marne, France My way to do FEVAR for optimal results Stéphan Haulon, Le Plessis-Robinson, France

Stroke from Thoracic Endovascular Procedures (STEP) controversies Chairing: Roger Greenhalgh, Imperial College, London, United Kingdom Reducing cerebral embolisation with experience of TAVI – key factors Simon Redwood, London, United Kingdom The use of filter protection in TEVAR patients – lessons learned from single- centre experience Mo Hamady, London, United Kingdom Systematic exclusion of air Fiona Rohlffs, Hamburg, Germany Tilo Kölbel, Hamburg, Germany Transcranial Doppler—the ultimate cerebrovascular technique for arch and supra-aortic trunk interventions Alan Lumsden, Houston, United States

This preliminary CX Programme is subject to change

8 Vascular & Endovascular Controversies Update 24–27 April 2018

Thursday 26 April 2018

PERIPHERAL CRITICAL ISCHAEMIA Peripheral arterial calcification—mechanism CONTROVERSIES of action, detection, classification and clinical Lower Main Auditorium implications Causes of vascular calcification Catherine Shanahan, London, United Kingdom  Improving outcomes of lower limb revascularisation—findings from a Character and localisation of arterial calcification nationwide routine dataset of 104,000 patients in England Renu Virmani, Gaithersburg, United States Ian Loftus, London, United Kingdom The impact of calcification on six months' efficacy when using drug-coated How to change a service and the stages of changing a service balloons in the superficial femoral artery—the SELUTION trial Cliff Shearman, Southampton, United Kingdom Thomas Albrecht, Berlin, Germany To save limbs, a multidisciplinary team is vital—the CLI Global Society Significance of calcification Marlon Spreen, Amsterdam, Netherlands approach Richard Neville, Annandale, United States Audience participation and discussion Peripheral arterial disease integrated care pathway Andrew Holden, Auckland, New Zealand Martin Fox, Manchester, United Kingdom Management of calcification—lithotripsy The national diabetic footcare audit (NDFA)—the hazard of delays in referral Lithoplasty for preparation of severely calcified lesions to interdisciplinary clinic with diabetologist and vascular surgeon Marianne Brodmann, Vienna, Austria William Jeffcoate, Nottingham, United Kingdom Treatment options to increase drug uptake in calcified vessels Audience participation and discussion Fabrizio Fanelli, Rome, Italy Popliteal artery injury associated with knee trauma The challenge of calcification Krishna Rocha Singh, Springfield, United States Martin Björck, Uppsala, Sweden Audience partcipation and discussion

The remaining place for distal bypasses in below-the-knee treatment TEA Eric Ducasse, Bordeaux, France Hands-on in City and Villages Preventing major amputation—the cost for the patient and the healthcare system Dominic Howard, Oxford, United Kingdom Audience participation and discussion In-stent restenosis

COFFEE Improvement of outcomes DCB-BTK vs. POBA: RCTs in China Wei Guo, Beijing, China Hands-on in City and Villages Improvement of outcomes DCB-BTK vs. POBA: RCTs in Italy Francesco Liistro, Arezzo, Italy Wound care roundtable Matrix metalloproteinase inhibitor dressing Endovascular bypass and venous arterialisation Michael Edmonds, London, United Kingdom Percutaneous femoropopliteal bypass—the DETOUR I trial Jihad Mustapha, Wyoming, United States Managing leg ulcers in the community—what is possible and feasible Manj Gohel, Cambridge, United Kingdom Outcomes of arterialisation of the foot veins—early experiences Andrej Schmidt, Leipzig, Germany Pedal bypass vs. endovascular tibial intervention for healing ischaemic foot wounds Eric Hager, Pittsburgh, United States Audience participation and discussion Novel nitric oxide release dressing Michael Edmonds, London, United Kingdom Audience participation and discussion Below-the-knee prosthetic bypass roundtable Walter Dorigo, Florence, Italy Use of paclitaxel-eluting peripheral stent in diabetic population CX ilegx 10 year celebrations & Bertrand Le Halle, Nancy, France Welcome to the CLI Global Society Podium 1st: Below-the-knee dedicated sirolimus-eluting stent Peter Goverde, Antwerp, Belgium Interdisciplinary Leg Initiative Lutonix DCB BTK registry Michael Lichtenberg, Arnsberg, Germany Audience participation and discussion

LUNCH

Hands-on in City and Villages

This preliminary CX Programme is subject to change

9 Years of Looking Forward - Plenary Programme

Friday 27 April 2018

Is there a role for CEA or CAS in preventing dementia? ACUTE STROKE CONTROVERSIES Charles McCollum, Manchester, United Kingdom Upper Main Auditorium Audience participation and discussion ACT 1—subgroup of women with lower stroke rate CAS vs. CEA Carotid controversies Kenneth Rosenfield, Boston, United States Audience participation and discussion Chairing: Ross Naylor, Leicester, United Kingdom Moderator: Hugh Markus, Cambridge, United Kingdom Is protamine reversal of heparin safe during CEA? John Kakisis, Athens, Greece CX Debate: Carotid endarectomy is safer than carotid artery stenting in the early time period after onset of symptoms Audience participation and discussion For the motion: Barbara Rantner, Innsbruck, Austria Against the motion: Peter Schneider, Honolulu, United States Cerebral and vertebral controversies Audience participation, discussion and polling CCSVI appraisal is again required Lindsay Machan, Vancouver, Canada CX Debate: Routine completion assessment is essential after carotid Quantitative analysis of embolic filter debris load during CAS in endarterectomy asymptomatic patients Franco Grego, Padua, Italy For the motion: Hans-Henning Eckstein, Munich, Germany Vertebral stenosis TBA Against the motion: Alun Davies, Imperial College, London, United Kingdom Vertebral stenosis TBA Audience participation, discussion and polling Audience participation and discussion CX Debate: The majority of patients neither require surveillance nor re- intervention after CAS/CAE For the motion: Ross Naylor, Leicester, United Kingdom Against the motion: William Gray, Wynnewood, United States Acute Stroke activities Audience participation, discussion and polling Acute Stroke Abstracts Page 18 CX Debate: Only patients with recurrent vertebrobasilar symptoms should be considered for vertebral artery stenting—the majority can be treated medically For the motion: Hugh Markus, Cambridge, United Kingdom Against the motion: Nelson Hopkins, Buffalo, United States Audience participation, discussion and polling CX Debate: There is no role for screening to detect asymptomatic carotid stenosis For the motion: TBA Against the motion: Andrew Nicolaides, London, United Kingdom Audience participation, discussion and polling COFFEE

Controversies panel US SCAFFOLD clinical study—novel stent results at 12 months William Gray, Wynnewood, United States Audience participation and discussion Why carotid guidelines are often biased or misleading Frank Veith, New York, United States Audience participation and discussion Is there a role for CEA/CAS in patients with severe carotid stenoses undergoing major non-cardiac surgery? Gert Jan de Borst, Utrecht, Netherlands Audience participation and discussion

CX Additional Sessions CX mission The goal of the Parallel Sessions is to provide delegates with opportunities to The Charing Cross Symposium raises vascular and enhance their skills in clinical practice. We offer a mix of educational talks and endovascular controversies so that a world-class faculty hands-on workshops. See below for details: challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms CX Venous Workshop—now in its 10th year! • a three-year cycle—in 2018, the CX programme is designed to raise controversies. CX Venous Techniques & Technologies • CX Vascular Masterclass CX Vascular Access Workshop CX programme and format CX Vascular Access Abstract Presentations All Charing Cross Symposia are distinguished by a unique CX Innovation Showcase •••• and logical programme, which focuses on identifying evidence for optimal vascular disease management from head to toe, NEW! CX Aortic Workshop • catering for all vascular specialists. CX Aortic Techniques & Technologies • Debate and emphasis on interaction with an expert audience NEW! CX Peripheral Workshop • are key aspects of the CX style. Education, Innovation and CX Peripheral Techniques & Technologies Evidence are CX core values. Short presentations and time-keeping are key characteristics of LINC@CX • the CX sessions; these enable the right time for comments and CX Meets Latin America •• questions by the audience. CEC@CX At the sessions, there is a chair who monitors time, encourages CX Congenital Vascular Malformations audience and speaker interaction and conducts the discussion; there is also a moderator who assists the chair CX Abstracts and Electronic Posters across all subject areas, with questions to and from the audience. including NEW! CX Global Stars and Rising Stars ••••

This preliminary CX Programme is subject to change

10 Vascular & Endovascular Controversies Update 24–27 April 2018

CX Venous Workshop, Venous City l Wednesday 25 April and Thursday 26 April

Now in its 10th year, the CX Venous Workshop is the largest of its kind and provides one-to-one demonstrations by world leading experts in a wide range of issues, interventions and technologies relating to venous and lymphatic systems. Running on Wednesday and Thursday, the Workshop comprises of multiple training stations devoted to diverse aspects of phlebology. Delegates are free to roam between stations at their convenience.

Part of the CX Venous Programme, the Workshop is one of several venous related activities this year at CX. There is also a whole day dedicated to Venous Controversies (see page 6).

Station, including (preliminary list): ABRE Diagnostic venous ISOBAR—custom fit Sclerotherapy for reticular Transvaginal duplex ultrasound compression veins and telangiectasia scanning Acute DVT imaging and clot ageing EKoSonic endovascular JetOne device Segmental ablation—NEW Tumescent anaesthesia system Air plethysmography Lymphatic imaging Silicone tubule implantation V-Block occlusion stent for Endophlebectomy and for severe lymphoedema varicose vein treatment Ambulatory phlebectomy Lymphoedema and Fistula Technique lipoedema—classification SnakeBack—NEW VariClose Angiojet and stents Endothermal management and management Steam Ablation Vascular ultrasound training Anti-DVT prophylaxis and of very large veins Molecular basis simulator medico-legal issues Strain gauge Endotherme 1470—NEW and embryology of plethysmography VenaSeal glue Aspirex S—NEW lymphoedema Foam phlebectomy Superficial vein thrombosis Veno-active agents, ASVAL Optimed venous portfolio Foam sclerotherapy for including ruscus extract and Surgical deep venous and Cancer-related thrombosis tributaries Paget Schroetter Syndrome sulodexide valve construction—NEW —NEW Foam sclerotherapy for Pelvic vein embolisation Venous embryology and Surgical procedures for Cannulation truncal reflux anatomy and virtual reality Photo-documentation — lymphoedema teaching Caval Filters Graded hydrotherapy for NEW Surgical treatment of lymphoedema—NEW CHIVA Prosthetic valve reticular veins Hand vein treatment options Technologies—NEW CLaCS (cryolaser and Thrombophilia assessment cryosclerotherapy) Investigation for occult Sclerotherapy for labial and in acute DVT malignancy after acute DVT pudendal veins—NEW CLEANER rotational thrombectomy system — NEW

ClosureFast

Comparison of CT, MR and IVUS

Compression bandaging techniques

Compression film bandaging

Conservative treatment and diagnostics of lypoedema/ lymphoedema—NEW

Device positioning

CX Venous Techniques & Technologies l Wednesday 25 April and Thursday 26 April

Now in its second year, the CX Venous Techniques & Technologies edited cases is an opportunity to review the latest techniques and technologies for managing venous disease. Running across two days at CX, the presentation of the cases has been timed to coincide with the CX Venous Workshop.

This preliminary CX Programme is subject to change

11 Years of Looking Forward

CX Vascular Access Masterclass

Wednesday 25 April This Masterclass will explore in-depth the challenges of complex vascular access. With the shifting demographic of the haemodialysis population, the need for complex access is becoming an increasingly common problem in practice.

While there is a range of solutions for this issue, the little published guidance that is available for complex vascular access is inconsistent and often lacks a robust evidence base to support it.

Therefore, the Masterclass will cover the range of scenarios presented to the clinician involved in vascular access with topics ranging from classification of end-stage vascular access, diagnostic difficulties and innovative approaches, individual management options with evidence and opinion from global experts through to new devices and novel technologies.

Embedded within the Masterclass will be short case presentations illustrating the clinical scenarios and provoking audience interaction. This is a first-of-its kind Masterclass and the most in depth examination into this difficult clinical area.

Classification and aetiology Innovations in vascular access: Technologies and Defining end stage vascular access (ESVA). Why does ESVA occur? What techniques, trial updates are the solutions? Epidemiology of vascular access failure Nicholas Inston, Birmingham, United Kingdom Percutaneous fistula updates Vein preservation and MAGIC (avoiding ESVA) The Ellipsys results—USA and Europe Jeffrey Hull, North Chesterfield, United States Katie Fielding, Derby, United Kingdom Alexandros Mallios, Paris, France Preventing central vein stenosis—why lines do bad things The EverlinQ study TBA Thomas Vesely, Saint Louis, United Statesl Arteriovenous crossing system first-in-man experience Vascular access in the arteriopath Hiren Mistry, London, United Kingdom Paul Hayes, Cambridge, United Kingdom Upper limb complex access Drug-coated balloons in vascular access TBA Five-minute case presentation: Failed RCAVF and no cephalic vein in Lutonix AV IDE final 18-month update upper limb following venepuncture Nicholas Inston, Birmingham, United Kingdom IN.PACT AV access procedural characteristics update Domenico Valenti, London, United Kingdom Andrew Holden, Auckland, New Zealand Autologous options. Forearm loop basilica vein transposition Grafts Maciej Zielinski, Poznan, Poland Humanity study Jeffrey Lawson, Durham, United States Upper limb arterial venous grafts—options and outcomes More than five-year experience with early cannulation graft Ulf Hedin, Stockholm, Sweden Matteo Tozzi, Varese, Italy Using neck veins for surgical access Jeffrey Hull, North Chesterfield, United States Flixene in vascular access James Gilbert, Oxford, United Kingdom Hybrid in complicated arteriovenous access cases Andrea Agostinucci, London, United Kingdom Panel discussion Pharmacological Pharmacological advances in vascular access TBA Lower limb access Patient-centred care: Optimising processes and Five-minute case presentation: Superior vena cava central stenosis Nicholas Inston, Birmingham, United Kingdom pathways Domenico Valenti, London, United Kingdom Patient-related outcome measures in vascular access (VA – PROMS) Femoral vein transposition vs. arterial venous graft—which is best Melanie Field, Birmingham, United Kingdom David Kingsmore, Glasgow, United Kingdom European Renal Best Practice vascular access guidelines update Arterial venous grafts in the thigh and groin Evi Nagler, Ghent, Belgium Paul Gibbs, Portsmouth, United Kingdom Learning from the Dialysis Outcomes and Practice Patterns study. Does HeRo in the leg TBA the type of access really affect survival? TBA Panel discussion: Case discussion and autologous vs. arterial venous graft vs. HeRO

Failed central veins Five-minute case presentation: Central venous occlusion superior vena cava and inferior vena cava? Nicholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom Classifying central venous occlusion TBA Cephalic arch stenosis: Treatment approaches and outcomes Dheeraj Rajan, Toronto, Canada Maintaining access in central venous catheters occlusion—role of central stents Robert Jones, Birmingham, United Kingdom “Inside out access” the surfacer—indications and outcomes TBA Exotic access; is there still a role for crossovers and opening chests? Domenico Valenti, London, United Kingdom Panel discussion: Best treatment for total venous occlusion LUNCH VA@CX2018 Prize for best abstract Vascular Access Presentation Winner 2017: Microvascular surgery for paediatric AV fistula formation—culture, technique and outcomes Petrut Gogalniceanu, London, United Kingdom

This preliminary CX Programme is subject to change

12 Vascular & Endovascular Controversies Update 24–27 April 2018

CX Vascular Access Workshop Thursday 26 April

This practical skills session will feature hands-on tutorials covering topics such as autologous Complications of access arteriovenous fistula access, implantation techniques for arteriovenous fistula grafts, and Thrombosis—diagnosis and treatments complications of access Ultrasound-guided angioplasty Central venous catheters Assessment of vascular access Complex access Dialysis central venous catheters workshop Ultrasound assessment and vein mapping Surgical treatment of vascular access aneurysms Central venous catheters thrombolysis—best HeRO and SuperheRO and Surfacer practice Techniques in vascular access EndoAVFs Autologous arteriovenous fistula EverlinQ Teaching and training in access Ellipsys vascular access Snuffbox arteriovenous fistula Cadaveric models for vascular access training— Radiocephalic arteriovenous fistula Dialysis made simple Dundee/Vascular Flow technologies Brachiocephalic arteriovenous fistula Needling techniques USS phantoms for USS and cannulation training Brachiobasilic arteriovenous fistula USS Guided needling (use of gel phantom simulator) TaCiDA and Kidney Academy  How does a dialysis machine work?

CX Vascular Access Abstract Presentations and Electronic Posters Tuesday 24 April

Selected and chosen by the CX Vascular Access Masterclass Chairs Nicholas Inston and Domencio Valenti, presentations are in two categories: (S) Senior and (T) Trainee. A prize of £500 will be awarded to the best abstract presentation and the winner will be announced at the end of the Vascular Access Masterclass on Wednesday.

The Lutonix global AV registry real-world patients with a dysfunctional AV Vascular Access abstracts presentations dialysis access—interim six month outcomes (S) Vascular access for home haemodialysis (T) Panagiotis Kitrou, Patras, Greece Julien Al Shakarchi, Halesowen, United Kingdom Clinical impact of patient’s demographics, comorbidities, anaesthesia, Endovascular management for salvage of arteriovenous fistula (T) haematological and biochemical markers on the primary maturation and Mohamed Ismail, Cairo, Egypt long-term survival of brachiocephalic fistulae (T) Surgical revision of the native arteriovenous fistula; experience of a single Ali Kordzadeh, Broomfield, United Kingdom centre (T) Pablo Justo Avila, Derby, United Kingdom Sheathless access using a novel balloon catheter (S) Screening and suitability of a UK population for the endovascular Angela Kokkosis, Dix Hills, United States creation of an ulno-ulnar AV fistula: Early single centre results an ongoing Independent impact of arteriovenous ratio index on the primary maturation controlled clinical trial (T) Aurangzaib Khawaja, Birmingham, United Kingdom of radiocephalic arteriovenous fistula (T) Use of covered stents in central vein stenosis following vascular accesses Ali Kordzadeh, Broomfield, United Kingdom (S) Carlo Maturi, Padova, Italy The surgeon significantly influences secondary patencies but not primary A comparison of surgical outcomes and patency rates following different patencies of PTFE shuntgrafts (T) Peter Konstantiniuk, Graz, Austria techniques for salvage of acutely thrombosed arteriovenous fistulas (T) Mechanical thrombectomy in acute thrombosis of dialysis fistulas using Bilal Azhar, London, United Kingdom the Indigo aspiration system: A multicentre study (T) Drug-coated balloon fistuloplasty for the treatment of failing arteriovenous Clement Marcelin, Bordeaux, France fistulas: Our experience (T) Vinit Paliwal, Gurgaon, India Multicentre RCT of paclitaxel-coated balloon compared to standard PTA in Randomised controlled trial comparing ultrasound and blind cannulation haemodialysis vascular access. Interim analysis of the first 100 patients in difficult to cannulate arteriovenous fistulae for dialysis access (T) (S) P.M.T. Pattynama, Gouda, Netherlands Joshua Kenneth Eves, Hull, United Kingdom A prospective randomised study comparing the use of paclitaxel-coated What do our patients think is important: Perspectives from a vascular PTA balloon catheters versus plain balloon PTA catheters to treat access specific patient-reported outcome measures questionnaire in a UK stenotic segments at the venous anastomotic site after thrombectomy for population (S) Melanie Field, Birmingham, United Kingdom thrombosed prosthetic vascular grafts for dialysis (T) Mohamed Rizk, Cairo, Egypt Focal force balloon plus drug-coated balloon new strategy for vascular access stenoses (S) Marco Franchin, Varese, Italy Rotary blood pump system rapidly dilates ovine cephalic veins prior to AVF surgery and improves AVF maturation (S) Non-invasive remote monitoring of vascular access health (T) Surendra Shenoy, St. Louis, United States Samit Gupta, Menlo Park, United States DCB in vascular access - where does it work (S) An early-cannulation nano-fibrous arteriovenous graft (ecAVG) for Tobias Steinke, Düsseldorf, Germany haemodialysis patients: An alternative to central venous catheter? (S) Jerzy Glowinski, Bialystok, Poland The effects of cannulation on arteriovenous dialysis grafts (AVG): A bench Vascular Access electronic posters top study (S) Nicholas Inston, Birmingham, United Kingdom Large brachial artery aneurysm following haemodialysis fistula ligation in a renal transplant patient: A case report (T) Evaluation of a novel portable battery-operated electrical stimulation Christiana Anastasiadou, Pefki, Greece device in vascular access (S) Aurangzaib Khawaja, Birmingham, United Kingdom Hybrid arterio venous fistula; a new approach for an old problem (T) Brachiobasilic arteriovenous fistula formation; the role of single stage Pablo Justo Avila, Derby, United Kingdom transposition (T) Pablo Justo Avila, Derby, United Kingdom Surgical management of a ruptured basilic vein aneurysm (S) Vascular external support device improves maturation: randomised Alban Malaj, Rome, Italy controlled multinational study results (S) Nikolaos Karydis, London, United Kingdom Vascular access construction. A constant creative attitude is required! (T) Pedro José Carvalho Pinto Sousa, Coimbra, Portugal

This preliminary CX Programme is subject to change

13 Years of Looking Forward

CX Innovation Showcase l l l l Thursday 26 April

Call for Innovation Novel embolisation devices Andrew Holden, Auckland, New Zealand We are currently looking for physician-inventors to share and discuss Aortic innovation their novel vascular and endovascular approaches at CX’s annual 3D printing for complex aortic endovascular procedures Bernhard Dorweiler, Mainz, Germany Dragons’ Den competition. The competition provides physician-inventors Endovascular valve-carrying conduit for the treatment of Type A aortic with the opportunity to present their ideas in front of a panel of medtech dissections Bartosz Rylski, Freiburg, Germany experts and to compete for the CX Innovation prize of £1,000. If you Gutterless chimney endograft Timur Sarac, New Haven, United States have a great idea, submit it by email to Pre-curved fenestrated endograft for aortic arch lesions Yoshihiko Yokoi, Tokyo, Japan [email protected] by 28th February 2018.

Course Directors: Stephen Greenhalgh, London, United Kingdom Venous innovation Andrew Holden, Auckland, New Zealand VB Foamer Device: Next-generation sclerotherapy Frans Moll, Utrecht, Netherlands Enric Roche, Sant Cugat del Valles, Spain SnakeBack: Standardisation of endovenous thermal techniques TBA Innovation controversies A novel non-implantable percutaneous approach to deep venous valve The myth of the lone inventor Frank Criado, Baltimore, United States failure TBA What impact—if any—will Brexit have on innovation? Alan Edwards, Ruthin, United Kingdom Vascular access innovation Are there opportunities for disruptive technologies in the vascular space? Stent Tek novel catheter system for minimally invasive vascular access Bob Mitchell, Irvine, United States Paul Hayes, Cambridge, United Kingdom The treacherous journey from an idea to a product Veinplicity electrical stimulation device for easier venous access TBA Timothy Clark, Philadelphia, United States The importance of “first in human” trials Diagnostic and imaging innovation Andrew Holden, Auckland, New Zealand Intraoperative positioning system: GPS-like interactive 3D vascular Matthew Eagleton, Cleveland, United States Overcoming the perils of early stage commercialisation imaging without fluoroscopy Julian Rieck, Speyer, Germany Hyperspectral imaging for superficial tissue oximetry Mark Darty, Memphis, United States Regulatory controversies VPI Reveal—advanced stereoscopic 3D/VR/AR visualisation solution Alternative regulatory strategies in the current regulatory environment Jan Heyligers, Tilburg, Netherlands Chas Taylor, Horsham, United Kingdom The new EU medical device regulations and the regulatory Cassandra Updates from previous Dragon’s Den winners syndrome Erik Vollebregt, Amsterdam, Netherlands 2015 The Bullet Proof vascular access graft (InnAVasc) Jeffrey Lawson, Durham, United States What will be the impact of the new medical device regulations on the industry? Gido Karges, Wangs, Switzerland 2016 Switch suturing device Mark Vrancken Peeters, Nijmegen, Netherlands What will be the impact of the new EU medical device regulations on 2017 FloGuardian anastomotic collar to reduce intimal hyperplasia innovation? Jeffrey Jump, Mont-sur-Rolle, Switzerland Stephen Barker, Shirley, United Kingdom Peripheral innovation Dragon’s Den First experience with Viabahn VBX in vitro Giovanni Torsello, Münster, Germany Chairing: Stephen Greenhalgh, London, United Kingdom Where are we with drug-eluting technologies? Dragon’s panel Bruno Scheller, Homburg/Saar, Germany Frans Moll, Utrecht, Netherlands; Andrew Holden, Auckland, New Zealand; Bob Mitchell, Irvine, United States; Daveen Chopra, Santa Rosa, United States; A new sirolimus drug-coated balloon technology: Insights from the Jason Field, Flagstaff, Arizona, United States; and Chas Taylor, Horsham, United Kingdom SELUTION SFA study Thomas Albrecht, Berlin, Germany The CUTNEEDLE for scalpel-free Seldinger Flex scoring catheter vessel preparation device Enric Roche, Sant Cugat del Valles, Spain Thomas Zeller, Bad Krozingen, Germany Holography for clinical interventions Elchanan Bruckheimer, Petach Tikva, Israel Serranator multiple serration scoring balloon Peter Schneider, Honolulu, United States Branched stent grafts and stent graft delivery system and methods Dean Yamaguchi, Greenville, United States DETOUR procedure for patients with long segment femoropopliteal disease Dainis Krievins, Riga, Latvia YORwalk mobile application Ahmed Shalan, York, United Kingdom LimFlow procedure for “no option” critical limb ischaemia patients Endovab embolic filter for peripheral arterial disease Dan Rose, Paris, France Linus Bosaeus, Stockholm, Sweden Krister Liungman, Uppsala, Sweden NEW! CX Aortic NEW! CX CX Peripheral Workshop l Peripheral Techniques & Wednesday 25 April and Workshop l Technologies l Thursday 26 April Wednesday 25 April and Wednesday 25 April Stéphan Haulon and the CX Aortic Thursday 26 April Programme Directors have put together this The cases will be transmitted from three practical skills course to provide delegates In the CX Peripheral Workshop—organised separate live case centres. Both the live cases with the opportunity to hear from globally by Andrew Holden and the CX Peripheral and edited cases will provide important insights recognised aortic experts and to try complex Programme Directors—world-class experts into the management of peripheral arterial aortic techniques and preprocedure planning will demonstrate a wide range of peripheral disease in clinical practice. tools at hands-on stations. technologies and techniques at hands-on stations, allowing delegates to test and improve their practical skills.

This preliminary CX Programme is subject to change

14 Vascular & Endovascular Controversies Update 24–27 April 2018

CX Congenital Vascular Malformations Tuesday 24 April

This session will address both high- and low-flow vascular malformations with regard to their treatment options. World experts will present classification systems that provide insight into various types of vascular malformations. The use of different embolic agents, and the results achieved with these, will be presented and debated by leaders in the field. The complementary role of surgery in the management of vascular malformations will also be discussed.

Introduction Krassi Ivancev, Hamburg, Germany Extreme and complex high-flow malformations Wayne Yakes, Englewood, United States Basic background and imaging COFFEE Moderator: Walter Wohlgemuth, Regensburg, Germany Moderator: Young Soo Do, Seoul, South Korea Debate Genetics and ISSVA Classification of Vascular Malformations Moderator: Krassi Ivancev, Hamburg, Germany Laurence Boon, Brussels, Belgium Moderator: Nick Wojtaszek, Warsaw, Poland How do I select patients and plan for treatment? Debate: Ethanol embolisation of vascular malformations has been proven Ian McCafferty, Birmingham, United Kingdom to be and is now the standard of care Robert Vogelzang, Chicago, United States When do I stop treating vascular malformations? For the motion: Mollie Atherton Meek, Little Rock, United States Jocelyn Brookes, London, United Kingdom Against the motion: Walter Wohlgemuth, Regensburg, Germany MR and CT imaging for high-flow and low-flow malformations Ian McCafferty, Birmingham, United Kingdom Walter Wohlgemuth, Regensburg, Germany Rebuttal: Robert Vogelzang, Chicago, United States Walter Wohlgemuth, Regensburg, Germany Low-flow malformations Mollie Atherton Meek, Little Rock, United States A classification of low-flow malformations and its treatment applications Ian McCafferty, Birmingham, United Kingdom Young Soo Do, Seoul, South Korea Conclusion and vote How do I treat low-flow malformations? Krassi Ivancev, Hamburg, Germany Ethanol embolisation for the cure of complex AVM: First-on-podium results Embolic agents for low-flow malformations Krzysztof Pyra, Warsaw, Poland of the Yakes vascular malformation centre Fiona Rohlffs, Hamburg, Germany Routine use of Ethanol in low-flow Malformations Complications and adjunctive surgical treatments of Nick Wojtaszek,Warsaw, Poland vascular malformations Extreme and complex venous and lymphatic low-flow malformations Moderator: Krzysztof Pyra, Warsaw, Poland management Wayne Yakes, Englewood, United States Moderator: Laurence Boon, Bruxelles, Belgium Complimentary role of surgery in vascular malformations in head and neck High-flow malformations Randolph C Robinson, Denver, United States Moderator: Robert Vogelzang, Chicago, United States Complimentary role of surgery in vascular malformations in body and Moderator: Jocelyn Brookes, London, United Kingdom extremities Tanya Oswald, Miami, United States Arteriovenous malformations: the Cho-Do Classification My worst complication and the lessons I learnt from it Young Soo Do, Seoul, South Korea Speakers: Krassi Ivancev; Robert Vogelzang; Ian McCafferty; Jocelyn Brookes; Arteriovenous malformations: The Yakes classification Laurence Boon; Wayne Yakes; Walter Wohlgemuth; and Nick Wojtaszek Fiona Rohlffs, Hamburg, Germany Summary and closing remarks Krassi Ivancev, Hamburg, Germany Treatment strategies for AVM derived from the Yakes classification Robert Vogelzang, Chicago, United States Techniques to define and approach the nidus Krassi Ivancev, Hamburg, Germany

LINC@CX l CX Meets Latin CEC@CX Thursday 26 April Wednesday 25 April America l l Programme directors: Wei Guo, Weiguo Fu , Zhong Chen This year, the LINC@CX programme will Thursday 26 April again feature recorded cases and lectures The China Endovascular Course (CEC) highlighting the latest techniques and In 2018, the Charing Cross Symposium comes to CX to provide an insight into the technologies for challenging critical limb will continue to have a dedicated session management of vascular disease in Asia. ischaemia patients. to showcase vascular and endovascular This session will provide an overview of the practice in Latin America. epidemiology, diagnosis, and treatment of type B aortic dissection, with a specific focus on China.

Open thoracoabdominal repair after failed TEVAR Best of aortic live Tilo Kölbel, Hamburg, Germany Roberto Chiesa, Milan, Italy CX Aortic Treating challenging thoracic anatomies with the Advanced techniques in endovascular management new Conformable TAG with the ACTIVE CONTROL of visceral aneurysm system Giovanni Torsello, Münster, Germany Mo Hamady, Imperial College, London, United Kingdom Techniques and  Treating the distal arch or residual type B Chimney EVAS Ian Loftus, London, United Kingdom dissections using a thoracic branch endoprosthesis Joe Bavaria, Philadelphia, United States Technologies l Conversion technique—from EVAR to open repair Michel Makaroun, Pittsburgh, United States Covered endovascular reconstruction of aortic Michel Reijnen, Amhem, Netherlands Tuesday 24 April Explantation of different EVAR devices with infection bifurcation Xavier Berard, Bordeaux, France CERAB Eric Verhoeven, Nuremberg Germany The aim of these edited cases is to explore the BEVAR Eric Verhoeven, Nurember, Germany Left subclavian FEVAR TBA application of different techniques in complex Prelaunch Valiant Evo Navion low profile thoracic TEVAR device with EndoAnchor thoracic and abdominal aortic procedures to Fabio Verzini, Pergua, Italy achieve the best outcomes for patients. Application of EndoAnchor for short (<10mm) aortic neck Frank Arko, Charlotte, United States

This preliminary CX Programme is subject to change

15 Years of Looking Forward

CX Abstract Presentations l l l l

Contemporary risk of bowel ischaemia after ruptured abdominal aortic Global Stars and Rising Stars—Abdominal Aortic aneurysm repair—a systematic review and meta-analysis (T) Eric Verhoeven, Nuremberg, Germany Chairing: Hamid Jalalzadeh, Amsterdam Zuid-Oost, Netherlands Chairing: Jan Brunkwall, Colgne, Germany Chairing: Benjamin Starnes, Seattle, United States Influence of proximal landing zone on long-term results after endovascular Chairing: Giovanni Torsello, Münster, Germany aneurysm sealing of abdominal aortic aneurysms (S) Patrick Berg, Kevelaer, Germany The clinical outcome of aortic aneurysms (growth rate and rupture): Prediction by studying the anatomy and genes Long-term outcome of elective surgery of abdominal aortic aneurysms in Carlota Fernandez Prendes, Oviedo, Spain Kakkhee Yeung, Amsterdam, Netherlands octogenarians (S) C3 module of the GREAT registry: Mid-term results of the C3 Excluder Long-term outcome of patients turned down for abdominal aortic stent graft Eric Verhoeven, Nuremberg, Germany aneurysm (AAA) surgery: A 5-year retrospective study (T) Alina-Maria Budacan, Birmingham, United Kingdom Aortoiliac and renal haemodynamic modifications after EVAS Celine Deslarzes-Dubuis, Lausanne, Switzerland Results of the Frontier III trial; large access hole vascular closure device based on fully absorbable patch (S) Arne Schwindt, Münster, Germany Mortality rates of ruptured abdominal aortic aneurysm repair have not changed with increasing utilisation of EVAR Long-term survival and preoperative predictors of mortality after elective Eric Hager, Pittsburgh, United States abdominal aortic aneurysm repair: A 10-year follow-up review (S) Sara Busto Suárez, Oviedo, Spain Superiority of standardised endovascular first strategy for patients with a ruptured abdominal aortic aneurysm: A multicentre prospective study from Ultrasound particle image velocimetry in the abdominal aorta: first results Japan Hidemitsu Ogino, Kamakura, Japan in humans and comparison with phase contrast magnetic resonance imaging (T) Stefan Engelhard, The Hague, Netherlands Self-made xeno-pericardial aortic tubes to treat native and aortic graft infections Thomas Wyss, Bern, Switzerland Analysing the Society for Vascular Surgery/American Association for Vascular Surgery scoring systems for outcomes post endovascular aortic Transcaval embolisation of type II endoleak after infrarenal and repair (T) Patrick Canning, Oranmore, Ireland fenestrated/branched endovascular aortic repair Franziska Heidemann, Hamburg, Germany Aortic neck angle-length index is a predictor for adjunct neck procedure during endovascular aneurysm repair in abdominal aortic aneurysm with Survival of octogenarians after uncomplicated EVAR equals life severe proximal neck angulation (S) expectancy of the general population Khamin Chinsakchai, Bangkok, Thailand Marie Josee Van Rijn, Rotterdam, Netherlands International consensus about which major complications following Aneurysm of the internal iliac artery—variations from open surgery to abdominal aortic aneurysm surgery to discuss with patients prior to endovascular functional reconstruction surgery: A Delphi study (T) Sylvana de Mik, Amsterdam, Netherlands Miriam Elizabeth Uhlmann, Vienna, Austria Current reporting of complications following aortic aneurysm surgery: A Early and mid-term outcome of multilayer flow modulator stent for systematic review (T) Sylvana de Mik, Amsterdam, Netherlands complex aortic aneurysm treatment in Germany Konstantinos Spanos, Larissa, Greece Analysis of aneurysm and endobag volumetric changes at mid-term follow-up after abdominal endovascular sealing using the Nellix device (S) The impact of preoperative psychosocial comorbidities on short-term Salma El Batti, Paris, France outcomes following elective aortic aneurysm repair Guy Martin, London, United Kingdom 18f-sodium fluoride is a novel independent predictor of abdominal aortic aneurysm growth and clinical outcome (T) Open repair of mycotic abdominal aortic aneurysms with biological grafts; Rachael Forsythe, Edinburgh, United Kingdom an international multicentre study Ivika Heinola, Helsinki, Finland Initial experience with the E-Iiac Iliac branch device for the endovascular A contemporary simple robust risk predictive model of 30-day mortality aortic repair of aorto-iliac aneurysms (S) Jan Peter Goltz, Lübeck, Germany after symptomatic abdominal aorta aneurysm Mohammad Eslami, Pittsburgh, United States In situ reconstruction using vascular xeno-pericardial grafts for life- threatening aorto-iliac infection (S) Wolfgang Hofmann, Feldkirch, Austria Combination of chimneys and fenestrated endografts in the treatment of complex aortic aneurysms Caroline Caradu, Bordeaux, France Are there sex-related differences in mortality after elective repair of an asymptomatic abdominal aortic aneurysm in The Netherlands? (T) Prospective study of a new generation iliac branch device in patients with Reza Indrakusuma, Amsterdam, Netherlands common iliac artery aneurysm: 12-month results Jan Brunkwall, Colgne, Germany Prophylactic mesh reinforcement after open abdominal aortic aneurysm repair to prevent incisional hernia? A systematic review and meta-analysis Automated planning software simplifies FEVAR and provides a definitive (S) Reza Indrakusuma, Amsterdam, Netherlands and far superior solution for short neck abdominal aortic aneurysms than currently exists Benjamin Starnes, Seattle, United States Non-perfused fresh frozen human cadavers; a practical model for endovascular training and research (T) Marloes Jansen, Utrecht, Netherlands One-year outcomes of the prospective European INSIGHT study with an ultra-low profile abdominal stent graft system Evaluation of national performance regarding surgical treatment for small Eleonora Karthaus, Leiden, Netherlands Giovanni Torsello, Münster, Germany abdominal aortic aneurysms (T) Outcomes of anterior spinal access performed by vascular surgeons (T) Abdominal Aortic Abstracts Kemal Kemal, Nottingham, United Kingdom Aortic neck changes and clinical results after endovascular aneurysm Growth rate of abdominal aortic aneurysms: Possible role of genetic repair using ALTURA D-shaped stent-graft: Three-year results (T) factors (S) Giada Sgorlon, Trieste, Italy Artis Knapsis, Düsseldorf, Germany Scrutinising the general applicability of the CE-approved chimney Less invasive EVAR procedure using a repositionable aortic stent graft procedure for short neck and juxtarenal aortic pathologies—109 assisted by IVUS imaging (S) Gaetano La Barbera, Palermo, Italy fenestrated endovascular aneurysm repair cases revisited (S) Afshin Assadian, Wien, Austria Applied machine learning for the prediction of growth of abdominal aortic aneurysm in humans (T) Regent Lee, Headington, United Kingdom Dynamics of EVAR stent volume changes in CT follow-up in abdominal aortic aneurysm patients (S) Mohamed Abdelmaksoud, Hessen, Germany Retrospective review of endovascular repair for mycotic aortic aneurysms (T) Yi Ting Lim,Singapore Long-term outcomes of elective endovascular repair of asymptomatic infrarenal aortic aneurysms with the Zenith stent graft (T) Endovascular aortic aneurysm repair in octogenarians: A single Mohammed Abdulrasak, Kristianstad, Sweden institution’s experience (T) Pravin Lingam,Singapore Open conversions after endovascular abdominal aneurysm repair: An Management of aortic graft infections and mycotic aneurysms: A eight-year single-centre experience (S) Iannis Ben Abdallah, Paris, France multidisciplinary team approach and in-situ reconstruction using biological neoaorta with promising early results (T) Surgeon reported evaluation of UK-wide provision of 24-hour Oliver Lyons, London, United Kingdom endovascular management of ruptured AAA (T) Ruth Benson, Birmingham, United Kingdom Fusion images, laser & fenestration in situ for complex aortic aneurysm using CTA image overlay: Feasibility study (S) Acidosis predicts perioperative mortality after surgical and endovascular Marek Majewski, Suresnes, France treatment for a ruptured abdominal aortic aneurysm (S) Alberto Froio, Monza, Italy Octogenarians undergoing open repair have higher mortality compared to fenestrated endovascular repair of intact abdominal aortic aneurysms involving the visceral vessels (S) Mahmoud Malas, Baltimore, United States The impact of endovascular aneurysm sealing versus endovascular aneurysm repair on the post-implantation inflammatory response (S) Ombretta Martinelli, Rome, Italy Tortuous iliacs in EVAR: Results and recommendations with the Excluder C3 (S) Isaac Martínez, Madrid, Spain

16 Vascular & Endovascular Controversies Update 24–27 April 2018

The VENT technique using Ovation stent graft for juxtarenal aneurysms in Local occlusion of the false lumen to treat thoracic aortic dissection patients with small iliac access vessels (T) Mariagnese Mele, Siena, Italy Bertrand Saint-Lebes, Toulouse, France Enhanced recovery after surgery in open aortic surgery (T) Liam Musto, Maidstone, United Kingdom Thoracic Aortic Abstracts Endovascular management of peri-aortic fibrosis. Mid-term outcomes (T) Takayasu’s arteritis with aortic aneurysm—outcome after open surgical Niall O’Reilly, Waterford, Ireland management (T) Pitchai Shivanesan, Thiruvananthapuram, India Late open conversions after endovascular abdominal aneurysm repair: A Mid-term results of proximal scalloped thoracic stent-grafts in 20-year multicentre experience (S) Paolo Perini, Parma, Italy endovascular aortic arch repair (S) Iannis Ben Abdallah, Paris, France Endovascular aneurysm sealing. Outcomes and anatomical suitability; a Morphologic study and volumetric evaluation of aortic diseases using a single-centre experience (S) Anna Prent, London, United Kingdom deformable surface model (S) Salma El Batti, Paris, France TrackCath system; new approach to cannulation (S) Fusion imaging significantly reduces contrast doses and radiation during Zoran Rancic, Zurich, Switzerland endovascular aortic repair (T) Susanne Anton, Lübeck, Germany Prevalence of myocardial injury after non-cardiac surgery (mins) in Irradiation reference levels during complex evar in a high-volume vascular EVAR patients —single-centre analysis using contemporary troponin I surgery centre (S) Vincenzo Brizzi, Bordeaux, France measurements (S) Joel Sousa, Oporto, Portugal Screening for abdominal aortic aneurysm during transthoracic Autologous superficial femoral vein for replacement of infected aortic echocardiography: A systematic review and meta-analysis (S) prosthetic graft (S) Robert Staffa, Brno, Czech Republic Christos Argyriou, Alexandroupolis, Greece Post-implanation syndrome following endovascular aneurysm sealing for Percutaneous access downsizing for early limb reperfusion in fenestrated/ abdominal aortic aneurysms (T) Kate Stenson, London, United Kingdom branched TAAA repair (T) Tommaso Cambiaghi, Milan, Italy Minimally invasive open surgical approach for late EVAR conversion (S) Comparison of fenestrated/branched endovascular and open surgical Francesco Stilo, Rome, Italy repair for suprarenal and type IV thoracoabdominal aortic aneurysms (S) Iannis Ben Abdallah, Paris, France Duplex ultrasound in pre-op planning for EVAR—minimising contrast- induced nephropathy (S) Peter Subramaniam, Adelaide, Australia Branched endovascular thoracoabdominal aortic repair with single step or staged procedures—a 10-year single-centre experience (S) Three year outcome of the covered endovascular reconstruction of the Reinhard Kopp, Regensburg, Germany aortic bifurcation (CERAB) technique for aortoiliac occlusive disease (T) Kim Taeymans, Edegem, Belgium Experimental in situ laser fenestration creates immediate substantial textile damages (T) Jérémie Jayet, Boulogne-Billancourt, France In-vitro evaluation of chimney and abdominal devices combinations by use of a flow-silicon model and computed tomography angiography (T) Open thoracic and thoracoabdominal aortic repair in patients with Gergana Taneva, Münster, Germany connective tissue disease (S) Drosos Kotelis, Aachen, Germany High annual hospital volume is associated with lower rates of adverse Outcomes after one-stage versus two-stage open repair of type II event rates following treatment of abdominal aortic aneurysms. Analysis of thoracoabdominal aortic aneurysm (S) Drosos Kotelis, Aachen, Germany nationwide German DRG data from 2005 to 2013 (S) Open thoracic and thoracoabdominal aortic repair as secondary Matthias Trenner, Munich, Germany conversion after prior endovascular therapy (S) Late open conversion after failed endovascular aortic aneurysm repair (S) Drosos Kotelis, Aachen, Germany Rosario Tringale, Catania, Italy Gender related access complications after TEVAR: data analysis from the Gender-related outcomes of the chimney endovascular repair of pararenal great registry (S) Chiara Lomazzi, San Donato Milanese, Italy aortic pathologies within the PERICLES registry (S) Comparison of supra-arch in situ fenestration and chimney techniques for Marco Virgilio Usai, Münster, Germany aortic dissection involving the left subclavian artery (S) Postoperative imaging follow-up at two years predicts long-term outcome Xiaohui Ma, Beijing, China after endovascular aortic repair (S) Suvi Vaaramaki, Tampere, Finland Increased displacement forces in proximal landing zone 3 for TEVAR in Isolated common iliac artery aneurysms treated solely with iliac branched patients with type III arch (S) stent-grafts: Early and mid-term results from a multicentre registry (S) Massimiliano Marrocco-Trischitta, San Donato Milanese, Italy Pierfrancesco Veroux, Catania, Italy Aortic curvature remodeling after TEVAR: Assessing device conformability Heparin during Non-Cardiac Vascular Interventions: Time to ACT ! (S) using image vector analysis (S) Gaspar Mestres, Barcelona, Spain Arno Wiersema, Amsterdam, Netherlands Mid-term outcomes with hybrid arch debranching repairs (T) Single-centre early experience of Aorfix and Altura Endovascular stent Kiyofumi Morishita, Hakodate, Japan grafts for abdominal aortic aneurysm repair (T) Branched endovascular repair for thoracoabdominal aneurysms – a single Ramesh Yap Kannan, Leicester, United Kingdom centre midterm experience (T) David Ormesher, Manchester, United Kingdom Updated instructions for use (IFU)—better results? How the new IFU Hybrid treatment for aortic embolisation-induced peripheral artery disease influence the outcome after endovascular aneurysm sealing (T) (S) Domenico Spinelli, Messina, Italy Sebastian Zerwes, Augsburg, Germany Two-year outcome of the endovascular aneurysm sealing system for Global Stars and Rising Stars—Peripheral Arterial treatment of abdominal aortic aneurysms (T) Chairing: Michael Lichtenberg, Arnsberg, Germany Aleksandra Charlotte Zoethout, Groningen, Netherlands Chairing: Gunnar Tepe, Rosenheim, Germany BIOLUX 4EVER // Physician-Initiated, prospective, multicentre (5), Global Stars and Rising Stars—Thoracic Aortic controlled trial investigating the efficacy of EV treatment of fempop arterial Chairing: Tilo Kölbel, Hamburg, Germany stenotic disease with Passeo-18 Lux drug-coated balloon & Pulsar-18 stent Chairing: Luca Bertoglio, Milan, Italy Koen Deloose, Dendermonde, Belgium Initial clinical results with the new BeGraft aortic covered stent in native BIOFLEX PEACE // All-Comers registry. Prospective, multicentre, for the coarctation of the aorta, restenoses and aneurysms treatment of stenosis and occlusion of the superficial femoral artery using Elchanan Bruckheimer, Petach Tikva, Israel the 4F PULSAR 18 stent Michael Lichtenberg, Arnsberg, Germany Long-term survival and visceral vessels patency following Two-year clinical outcomes of the CONSEQUENT trial: Can femoropopliteal thoracoabdominal aortic open repair for different pathologies lesions be treated with sustainable clinical results that are economically Andrea Kahlberg, Milan, Italy sound? Gunnar Tepe, Rosenheim, Germany Percutaneous axillary artery access for fenestrated and branched 12-month clinical follow-up of the Multi-LOC multiple stent delivery system thoracoabdominal endovascular repair Luca Bertoglio, Milan, Italy for focal stenting in long femoropopliteal lesions Aortic arch aneurysm repair by means of frozen elephant trunk with arch- Klaus Amendt, Mannheim, Germany first technique Luca Bertoglio, Milan, Italy Supervised exercise training (SET) increases apoptosis in the Multi-staged endovascular repair of thoracoabdominal aneurysms with symptomatic calf and thigh in patients with intermittent claudication fenestrated and branched endografts Luca Bertoglio, Milan, Italy Hong-Yau Tan, Bedford Park, Australia Prevalence of bovine aortic arch variant in patients with aortic dissection Drug-coated balloons vs. balloon angioplasty in bypass vein grafts: A and its implication in outcome of patients with acute type B aortic randomised, controlled study with one-year follow-up (the DRECOREST- dissection Spyridon Mylonas, Cologne, Germany study) Patrick Björkman, Helsinki, Finland Surveillance recommendations following TEVAR should be based on initial Impact of patient and lesion characteristics on drug-coated balloon indication for repair Ravi Rajani, Atlanta, United States angioplasty of the femoropopliteal artery—pooled subgroup analysis of four randomised controlled multicentre trials Thomas Albrecht, Berlin, Germany Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries. Twelve-month results of the BIOLUX P-III all-comers registry for the full cohort Marianne Brodmann, Graz, Austria

17 Years of Looking Forward

Ultrasound guided superficial femoral artery percutaneous access for the The effectiveness of the paclitaxel-coated Luminor balloon catheter versus treatment of ipsilateral distal arterial atherosclerosis disease an uncoated balloon catheter in superficial femoral and popliteal arteries Alejandro Gonzalez Ochoa, San Luis, Mexico in preventing vessel restenosis or reocclusion: 12 months results of a Ulf Teichgraeber, Jena, Germany BioMimics 3D; the swirling flow stent: One-year results of the MIMICS-2 randomised controlled trial (S) study Thomas Zeller, Bad Krozingen, Germany Tissue-engineered blood vessels with user-defined geometries— Benefits and cost-effectiveness of heparin-coated versus standard graft— technology for the future of vascular grafting (T) Sam Pashneh-Tala, Sheffield, United Kingdom final five-year results from the Scandinavian Propaten trial Jes Lindholt, Viborg, Denmark Use of the Tigris vascular stent in advanced femoropopliteal peripheral Pierleone Lucatelli, Rome, Italy Contrast-enhanced ultrasound visualization of micro-channels can identify arterial disease (S) occlusions suitable for luminal endovascular crossing One-year outcomes of endovascular device intervention in patients with Ian Spark, Adelaide, Australia symptomatic lower extremity peripheral arterial disease (LIBERTY 360) (S) Mazin Foteh, Austin, United States Endovascular treatment of severe TASC C&D lesions with stent graft Michele Antonello, Padua, Italy Safety and effectiveness of hybrid surgery compared to aortofemoral Tracking of arteriogenic monocytes to salvage the ischaemic limb—a bypass grafting in treatment of iliac occlusive disease (TASC C, D) and concomitant lesion of common femoral artery: A randomised clinical trial; bench to bedside study Ashish Patel, London, United Kingdom intermediate results (S) Pavel Ignatenko, Novosibirsk, Russia Percutaneous deep venous foot arterialization. A new technique for Study of apolipoprotein-b (apo-b)/apolipoprotein-a1 (apo-a1) ratio in creating arterio-venous fistulas Bruno Migliara, Peschiera, Italy patients with lower limb critical ischemia and its effect on outcomes after Factors, conditions and treatment can enhance tissue regeneration in revascularisation (T) Lawish Agarwal, Bangalore, India ischaemic foot-wounds after revascularization Biotechnology is a new way for treatment of “no option” patients with Magdiel Trinidad Vazquez, Guadalajara, Mexico recalcitrant chronic ulcers (S) Ivan Barna, Kiev, Ukraine Investigation of female gender as a risk factor for outcomes following Peripheral Arterial Abstracts presentation with severe limb ischaemia in the setting of the randomised Long-term results of treatment of extensive steno-obstructive iliac artery BASIL trial (T) Ruth Benson, Birmingham, United Kingdom lesions with self-expanding covered-stent (S) Filippo Benedetto, Messina, Italy Mid-term outcomes after popliteal artery stenting in the specific subset of Cost-effectiveness analysis of a multicentre randomized controlled trial patients with critical limb ischaemia (S) Aurélia Bianchini, Valenciennes, France (SUPER): Endovascular revascularisation or supervised exercise therapy The effect of percutaneous flexor tenotomy on healing and prevention of for intermittent claudication due to iliac artery obstruction (T) foot ulcers in patients with claw deformity of the toe (T) Nick S. van Reijen, Amsterdam, Netherlands Sophie de Gier, Doetinchem, Netherlands Prevalence of peripheral arterial disease in the old and very old Neurostimulation: A novel option for severe peripheral arterial disease in population: an epidemiologic approach to the situation in German nursing absence of suitable revascularisation treatment (S) homes Payman Majd, Cologne, Germany Abul Quddus, Stockport, United Kingdom Impact of calcification on six months efficacy when using a DCB in the NOVEL technique to tackle flush superficial femoral artery chronic total SFA. Insights from the SELUTION trial: A novel sirolimus coated DCB occlusion (S) Ahmed Naga, Alexandria, Egypt technology evaluated in SFA (S) Thomas Albrecht, Berlin, Germany Screening for PAD in patients with diabetic foot ulceration (S) Clinical results of the surgical reconstruction versus peripheral Bianca Vriens, Colchester, United Kingdom intervention in patients with critical limb ischaemia (SPINACH) study: Usefulness of WIfI classification for selection of revascularisation Stent versus bypass for femoropopliteal TASC II Type C and D lesions— procedure (S) Nobuyosh Azuma, Asahikawa, Japan preliminary data of a prospective randomised trial (T) Florian Enzmann, Salzburg, Austria Transplantation of autologous bone marrow derived mononuclear cells and bone marrow aspirate in patients with non-reconstructable peripheral arterial disease (S) Ivan Barna, Kiev, Ukraine Global Stars and Rising Stars—Acute Stroke Pharmacology for peripheral arterial disease in the Netherlands; patient Chairing: Ross Naylor, Leicester, United Kingdom journey and platelet aggregation inhibitor prescription (T) Chairing: Hugh Markus, Cambridge, United Kingdom A.R.T. Brand, Utrecht, Netherlands Quantitative analysis and predictors of embolic filter debris load, during Results of dual component stent in critical limb ischemia as provisional or carotid artery stenting in asymptomatic patients Michele Piazza, Padua, Italy primary stenting in “de novo” and restenotic lesions of superficial femoral and popliteal arteries (S) Jorge Cuenca, Granada, Spain The role of VWF, ADAMTS13 and inflammatory response in the outcome of acute ischaemic stroke mechanical thrombectomy procedure Morphometric predictors of mortality, morbidity and length of hospital stay Vaclav Prochazka, Ostrava, Czech Republic following lower limb revascularisation (S) Maciej Juszczak, Oxford, United Kingdom Distribution of gas during thoracic endovascular aortic repair in an aortic flow model Vladimir Makaloski, Hamburg, Germany Long-term outcome of a randomised trial comparing endovascular revascularisation plus supervised exercise with supervised exercise only for intermittent claudication (T) Sanne Klaphake, Rotterdam, Netherlands Acute Stroke Abstracts Low toe pressure is associated with poor long-term survival and low A single centre experience using automated intracranial pressure- contralateral toe pressure further shortens survival in symptomatic PAD controlled cerebrospinal fluid external drainage (S) patients (T) Juha Virtanen, Turku, Finland María Pilar Lamarca Mendoza, Toledo, Spain Characterisation the human ITB1 gene as a modulator of neo angiogenesis Sonographic biomarkers of carotid artery disease and cognitive and a candidate therapeutic target for cardiovascular disease (S) impairment in stroke-free adults: a systematic review (T) Daniela Mazzaccaro, San Donato Milanese, Italy Alexander Coupland, London, United Kingdom EffPac trial—effectiveness of Luminor DCB versus POBA in the SFA: Acute ischaemic stroke: Role and timing of carotid endarterectomy for Primary endpoint and six months results (S) Ulf Teichgraeber, Jena, Germany internal carotid occlusion (S) Pierfilippo Acciarri, Ferrara, Italy Femorodistal sequential bypass for advanced peripheral arterial disease: Outcomes after eversion carotid endarterectomy: a comparison between results of a contemporary series of more than 100 operations (S) typical and glomus-sparing technique (S) Achim Neufang, Weisbaden, Germany Konstantin Andreychuk, St Petersburg, Russia Outcomes of octogenarians following lower extremity open Clinical and cytological correlation in the vulnerable atherosclerotic revascularisation (S) Paul Lajos, New York, United States carotid plaque: Monocentric experience (S) David Barilla, Messina, Italy Peripheral angiography by contrast-enhanced 3D tomographic ultrasound Perioperative haemodynamics and cerebral monitoring of carotid (S) Steven Rogers, Manchester, United Kingdom endarterectomy patients: A Dutch Audit (T) Leonie Fassaert, Utrecht, Netherlands Preliminary results of the Italian Multicentre Registry using a dual component vascular stent for the treatment of distal SFA with or without Transcarotid Stenting with Reverse Flow Neuroprotection is a safe and involvement of popliteal artery (S) Maria Antonella Ruffino, Turin, Italy effective alternative to Carotid Endarterectomy for High-Risk Patients (S) Mazin Foteh, Austin, United States Primary stenting of the superficial femoral artery in patients with intermittent claudication has durable effects on health-related quality of Completion angiography following carotid endarterectomy: findings, life at 24 months—results of a randomised controlled trial (S) reliability and clinical relevance (T) Jasmin Dillner, Magdeburg, Germany Hans I.V. Lindgren, Helsingborg, Sweden Emergency internal carotid artery stenting for acute occlusion after Randomised trial comparing effectiveness and safety of three endarterectomy (S) Marco Leopardi, L’Aquila, Italy percutaneous arterial closure devices vs. manual compression in Age modifies the efficacy and safety of carotid artery revascularisation peripheral interventions (S) Javier Peinado Cebrián, Toledo, Spain procedures: Analysis of the vascular quality initiative registry (S) Mahmoud Malas, Baltimore, United States Short non-patch arteriotomy in carotid endarterectomy (S) Marco Leopardi, L’Aquila, Italy

18 Vascular & Endovascular Controversies Update 24–27 April 2018

Statins reduce mortality and failure to rescue following carotid artery Ultrasound evaluation of calf deep vein thrombosis and residual vein stenting (S) Mahmoud Malas, Baltimore, United States obstruction after low molecular weight heparin treatment (S) Evren Özçinar, Ankara, Turkey Carotid artery plaque echomorphology and its association with histopathological characteristics (S) Konstantinos Spanos, Larissa, Greece Deep vein insufficiency in magnetic resonance imaging at various Improved strategies for the treatment of malignant carotid body tumor: compression levels of CircAid JuxtaLite system—proof-of-concept study Cezary Szary, Warsaw, Poland intraoperative regional lymph node biopsy and surgical technique (S) modification (S) Yuehong Zheng, Beijing, China Single-centre experience of the Sentry bioconvertible inferior vena cava Vascular Societies’ recommendations and daily practice—carotid filter: A paradigm shift in pulmonary embolism protection (S) Robert Mendes, Lillington, United States endarterectomy with primary suture in single surgeon material (S) Piotr Myrcha, Warsaw, Poland Prospective double-blind randomised controlled trials comparing Twenty-eight years of the surgical treatment of the subclavian steal electrocoagulation and radiofrequency in the treatment of patients with great saphenous vein insufficiency and lower limb varicose veins (S) syndrome - a single centre experience (T) Piotr Kaszczewski, Warsaw, Poland Fabio Rossi, São Paulo, Brazil Global Stars and Rising Stars—Venous Role of injection pressure, flow and sclerosant viscosity in causing cutaneous ulceration during sclerotherapy (S) Chairing: Ian Franklin, London, United Kingdom Kasuo Miyake, São Paulo, Brazil Chairing: Stephen Black, London, United Kingdom Chairing: Alun Davies, London, United Kingdom Circumferential suction-assisted lipectomy in the treatment of primary and secondary end-stage lymphoedema of the leg (S) Randomised double-blinded study comparing medical treatment versus Alexander Lamprou, Drachten, Netherlands iliac vein stenting in chronic venous disease Fabio Rossi, São Paulo, Brazil Novel strain gauge plethysmography (T) Albert Kota, Vellore, India Local matrix metalloproteinases respond to gravitational position and compression in patients with advanced venous disease Skipped lesion at iliocaval confluence: Another technique for stenting in Christopher Lattimer, Southall, United Kingdom chronic venous obstructions (S) Houman Jalaie, Aachen, Germany Single session femoropopliteal venoplasty for chronic post-thrombotic Role of inferior vena cava filter insertion prior to thrombolysis of acute obstruction Angela Kokkosis, Dix Hills, United States iliofemoral deep venous thrombosis (T) Mohamed Ismail, Cairo, Egypt Catheter directed thrombolysis versus suction thrombectomy in the A unique bioconvertible inferior vena cava filter: Two-year results from the management of acute pulmonary embolism SENTRY study (S) Michael Dake, Stanford, United States Efthymios Avgerinos, Pittsburgh, United States Which factors influence the severity of PTS syndrome? (S) Imaging of iliocaval obstructions in preparation of percutaneous Beatrix Cucuruz, Nürnberg, Germany transluminal venoplasty and stenting Oliver Schlager, Vienna, Austria Early results of endovascular iliocaval reconstruction with stents for Mechanochemical ablation vs. thermal ablation in great saphenous vein venous outflow obstruction secondary to post-thrombotic syndrome (T) insufficiency: Results of a randomised controlled trial James Budge, London, United Kingdom Sari Vahaaho, Espoo, Finland Long-term outcomes of endovascular treatment in large veins (S) The utility of a discord outcome analysis as a reporting standard in Ricardo Costantini, Pilar, Argentina randomised clinical varicose vein trials Evi Kalodiki, London, United Kingdom Detecting stent geometry changes after venous recanalisation using duplex ultrasound (T) Mohammad Esmaeil Barbati, Aachen, Germany Venous Abstracts A multicentre randomised controlled trial evaluating the efficacy of REVAS—is there a place for religation of the saphenous femoral junction dehydrated human amnion/chorion membrane (DHCAM) (EPIFIX) allograft in 2017? (S) Maria Jose Ferreira Barbas, Lisbon, Portugal for the treatment of venous leg ulcers (S) Christian Bianchi, Loma Linda, United States Endovascular management of acute lower limb deep vein thrombosis: A systematic review & meta-analysis (T) Radiation exposure of patients with post-thrombotic syndrome during , Aachen, Germany Matthew Thomas, Durham, United Kingdom venous recanalisation (T) Mohammad Esmaeil Barbati The V-block occlusion stent for varicose vein treatment (S) Ralf Kolvenbach, Düsseldorf, Germany

CX Electronic Posters l l l l

The Electronic Posters will be available for viewing during the entire symposium on screens placed in a dedicated area on the exhibition floor. Using the latest multimedia, interactive and smart database technology, the Electronic Posters will run continuously on a loop and can be selected for static viewing via a touch screen. Additionally, selected Posters will be presented in a special session

Abdominal Aortic Clinical application of 3D image fusion guidance during EVAR: A single- centre assessment of its beneficial role in reducing contrast-induced Impact of an integrated vascular centre on abdominal aortic aneurysm nephropathy and radiation hazard (S) Nam Yeul Yim, Gwangju, Korea South repair (S) Ondrej Stehno, Harrow, United Kingdom Endovascular treatment of isolated hypogastric artery aneurysms (T) Abdominal aortic aneurysm size affects outcome after endovascular Sara Busto Suárez, Oviedo, Spain treatment (S) Mariano Castelli, Buenos Aires, Argentina Re-entry devices for lamella neo-fenestration during endovascular aortic Age-related arteriopathy assessment: Should future abdominal aortic repair of chronic type-B aortic dissection (T) Tommaso Cambiaghi, Milan, Italy aneurysm screening criteria be determined by age? (T) Mohamed Elsharkawi, Galway, Ireland Physician modified fenestrated PTFE cuff to treat an infrarrenal abdominal aortic aneurysm with bilateral accessory renal arteries: initial experience The use of EndoAnchors to rescue complicated EVAR procedures (S) (S) Mariano Castelli, Buenos Aires, Argentina Luis Mariano Ferreira, Buenos Aires, Argentina Trend in the treatment of ruptured abdominal aortic aneurysm (EVAR vs. The use of EVAS in patients unfit for open surgery and with compromised open reapir) from 2005 to 2016 and its influence on outcome (S) infrarenal aortic neck consider unfit for conventional EVAR or F/BEVAR (S) Stefano Chiarandini, Trieste, Italy Pekka Aho, Helsinki, Finland Discontinued antibiotic following endovascular aneurysm repair for Incidence of identifying abdominal aortic aneurysm via a computed infected abdominal aortic aneurysm is better outcomes than persistent tomography scan and its implication on prevalence in Saudi Arabia (S) infection (S) Khamin Chinsakchai, Bangkok, Thailand Faris Alomran, Paris, France A comparison of the outcomes of open repair, fenestrated stent grafting, Medway Maritime Hospital experience with one-day hospital stay for EVAR and chimney grafting in juxtarenal abdominal aortic aneurysm: Is it time (T) Hj Hammawa, Coventry, United Kingdom for a randomised trial? (S) Khamin Chinsakchai, Bangkok, Thailand A systematic review and meta-analysis of open and endovascular repair The utility of dynamic computed tomography angiography in the study of for mycotic aortic aneurysms (T) Yin Ting Liau, Singapore endoleaks after endovascular aneurysm repair (T) Infected abdominal aortic aneurysm treated with endovascular aneurysm Gabriela Gonçalves Martins, Barcelona, Spain sealing (S) Thoetphum Benyakorn, Phatumthani, Thailand Loco-regional versus general anaesthesia for endovascular aneurysm Long-term outcomes of endovascular treatment for isolated internal iliac repair (T) Shahab Hajibandeh, Salford, United Kingdom artery aneurysms (S) Masato Yamaguchi, Kobe, Japan EVAS in the emergent endovascular treatment of early and late Role of endostapling in expanding EVAR feasibility (T) complications after open aortic surgery and iatrogenic aortic lesions (S) Roberto Bisceglie, Rome, Italy Ulrich Kugelmann, Gunzburg, Germany

19 Years of Looking Forward

Validating the use of contrast-induced nephropathy prediction models in Peripheral Arterial endovascular aneurysm repair (S) Zhiwen Joseph Lo, Singapore Surgeon modified stent graft: Feasible endovascular bailout in emergency! Infra renal aortic aneurysm associated with external or comum iliac artery (T) Tamer Sayed, Hove, United Kingdom occlusion (S) Guilherme Meirelles, Campinas, Brazil Radiation dose data of purely infra-inguinal endovascular Do complex cases have the same evolution as simple cases in revascularisation for treatment of critical limb ischaemia (T) endovascular aneurysm repair? (T) Vaibhav Lende, Bangalore, India Matias Rafael Mon Noboa, La Plata, Argentina Technical difficulties faced during the deployment of the interwoven nitinol Outcomes of patients turned down for elective abdominal aneurysm stents for femoropopliteal disease (T) Vaibhav Lende, Bangalore, India surgery (T) Rebecca Preston, Leeds, United Kingdom Technique and complications of extended iliofemoral eversion Is mesenteric artery calcification a predictor of symptomatic chronic endarterectomy for severe iliofemoral arterial disease (T) mesenteric ischaemia? A computed tomography imaging-based study (T) Gautamn Sarwal, Vancouver, Canada Umar Sadat, Cambridge, United Kingdom Wound healing in critical limb ischaemia with no named vessel outflow in Cost-effectiveness of open repair for ruptured abdominal aortic aneurysm the foot (T) Vaibhav Lende, Bangalore, India (S) Peter Subramaniam, Adelaide, Australia Decrease of peripheral resistance after intraoperative administration “Second life” of the extra-anatomical bypass grafts (S) of iloprost in diabetic and non-diabetic patients with peripheral arterial Malgorzata Szostek, Warsaw, Poland occlusive disease (S) Kornelia Hirsch, Vienna, Austria Factors affecting the mortality of endovascular stent treatment in infected Management of acute upper extremity ischaemia: Treatment strategies and aortic aneurysms (T) Kullacha Taruetiyaputranon, Songkhla, Thailand outcome (T) Lawish Agarwal, Bangalore, India Aetiological evaluation of aneurysm of the abdominal part of aorta by A Mexican regional experience on infragenicular distal bypass for limb immunohistochemical analysis results of the aorta changed wall biopsies salvage (S) Erasto Aldrett Lee, San Luis Potosi, Mexico (T) Ekaterina Zvereva, St Petersburg, Russia Mid-term results of hybrid operations in multilevel peripheral arterial Factors influencing the timeline for complex endovascular treatment disease (S) Pavel Bondarenko, St. Petersburg, Russia of aortic aneurysms other than manufacturing time of custom made Drug-eluting stent use in femoropopliteal disease—results from a endografts (T) Ewa Zywicka, Aylesbury, United Kingdom retrospective, single-centre, real-world study (T) Hybrid abdominal aortic repair Mustafa Akbulut, Istanbul, Turkey Mark Earle, Newfoundland, Canada Predictor of major adverse anatomical events after endovascular Silver coated graft as bailout option for managing femoral artery infected aneurysm repair (T) Mohammed Elkassaby, Galway, Ireland pseudoaneurysm: A review of 30 patients (T) Ahmed Allam, Benha, Egypt Management of acute arterial mesenteric ischemia in a tertiary care centre Stenting: A no-stenting zone? (S) Maxime Elens, Brussels, Belgium (S) Lawish Agarwal, Bangalore, India Alternative use of re-entry device combined with retrograde advancement of a “snare loop” device to achieve a chronically occluded superficial Thoracic Aortic femoral artery recanalisation without detectable origin (S) Endovascular rescue of acute aortic dissection-mediated malperfusion Roberto Gandini, Rome, Italy syndromes (S) Dean Yamaguchi, Greenville, United States A prospective, multicentre, randomised controlled trial evaluating the Endovascular treatment of thoracoabdominal aortic aneurysms using safety and efficacy of the paclitaxel-coated peripheral balloon dilatation multi-branched stent grafts (S) catheter (APERTO OTW) for the treatment of arteriovenous fistulae Enrique María San Norberto García, Valladolid, Spain stenosis in patients undergoing haemodialysis (S) Qizhuang Jin, Beijing, China Our experience in hybrid surgical treatment of thoracic aortic aneurysm (S) Pavel Bondarenko, St. Petersburg, Russia Qualitative assessment of carbon dioxide as a contrast agent for infra- inguinal arterial diagnostic and therapeutic procedures in patients with Immediate and short-term outcomes of hybrid thoracic endovascular chronic kidney disease and critical limb ischaemia (T) aneurysm repair—a single-centre retrospective study (T) Dharmeshkumar Davra, Bangalore, India Pitchai Shivanesan, Thiruvananthapuram, India First results after use of biosynthetic prosthesis in vascular graft Endovascular management of mycotic aortic aneurysms: A 15-year single infections (T) Cristina Lozano Ruiz, Albacete, Spain centre experience (T) Gary Andrew Cuthbert, Leeds, United Kingdom Thirteen years experience of peripheral arterial disease intervention in a Transapical endovascular aneurysm repair of type IA endoleak (T) tertiary referral centre (T) Mohamed Elsherif, Galway, Ireland Daniel Gil-Sala, Barcelona, Spain Neutrophil to lymphocyte ratio as a marker of TASC II class in patient with Diagnostic value of mediastinal/chest ratio in blunt traumatic aortic injury peripheral arterial disease (S) Olexondr Voloshyn, Zaporozhye, Ukraine (T) Chawakorn Leampriboon, Muang, Thailand Retrograde re-entry technique using the Outback catheter for treatment of Comparison study on ascending aortic characteristics in patients with peripheral arterial chronic total occlusive disease: Technical feasibility and degenerative arch aneurysms and type B aortic dissection with aneurysm safety (T) Nam Yeul Yim, Gwangju, South Korea changes (T) Che Lok Felix Chow, Hong Kong Popliteal artery occlusion following orthopaedic procedures— Challenging endovascular treatment in complicated thoracoabdominal management dilemma (T) Maki Jitsumura, Wrexham, United Kingdom aneurysm (S) Cristina Lozano Ruiz, Albacete, Spain Paediatric arterial trauma of extremities with palpable distal pulse (S) Is it possible to predict the need for cerebrospinal fluid drainage in Adel Kamhawy, Tanta, Egypt patients undergoing elective endovascular repair of thoracic and thoracoabdominal aortic disease using the collateral network concept? (T) Effect of supervised exercise, home-based exercise and endovascular Mario D'Oria, Trieste, Italy revascularisation on physical activity in patients with intermittent claudication: A network meta-analysis (T) Endovascular repair of thoracoabdominal and pararenal aortic aneurysms: Marijn van den Houten, Eindhoven, Netherlands A single-centre early experience (S) Rocco Giudice, Roma, Italy Prognostic value of the Society for Vascular Surgery Wound, Ischemia, Management of leaking thoracic aortic pathologies—a single-centre and foot Infection (WIfI) classification in patients with no-option chronic experience (T) Prakash Goura, Trivandrum, India limb-threatening ischaemia (T) Steven van Haelst, Utrecht, Netherlands Geometrical remodelling of the aortic arch after hybrid treatment (S) Iliac-popliteal bypass using a transobturator approach as a chance for Giovanni Spinella, Genoa, Italy infrainguinal revascularisation in patients with compromised groin due to Genetics are only the weakening factors of the aortic wall in type A, B infection (S) Gladiol Zenunaj, Ferrara, Italy aortic dissections; the real cause is the kinetic force (S) Bypass in the leg after failed endo repair: Do the results compare to first- Ernö Remsey-Semmelweis, Marburg, Germany line bypass? (S) Julien Sfeir, Beirut, Lebanon Debranching of supra aortic vessels for complex thoracic aorta disease Bovine pericardial patch—a good alternative in femoral angioplasty (S) and TEVAR landing in zones zero and one (S) Katariina Noronen, Helsinki, Finland Salvatore Alberto Turiano, Catania, Italy Comparative study of vascular grafts produces by electrospinning (S) Stiffness mismatch between native aorta and endograft increases risk of Irina Popova, Novosibirsk, Russia ascending aortic rupture following thoracic endovascular aortic repair (T) Theodorus van Bakel, Ann Arbor, United States Comparison of expandable, detachable gold metal balloons with nitinol vascular plugs and platinum coils in canine model of arterial occlusion (S) A rare cause of massive gastrointestinal blood loss (T) Kieran Murphy, Toronto, Canada Karen Van Langenhove, Ghent, Belgium Digital subtraction angiography versus kinetic imaging: Comparison through randomised trial (T) Viktor Orias, Budapest, Hungary Vascular Malformations Imaging potential autologous veins for arterial bypass (S) Congenital vascular malformations: Modern congenital vascular Steven Rogers, Manchester, United Kingdom malformations; modern strategy in diagnostics and treatment (S) Long-term results of heparin-bonded, expanded polytetrafluoroethylene Larysa Chernukha, Kiev, Ukraine stent graft in the treatment of TASC C and D long femoropopliteal lesions Management of iliac vein comprssion coexisting with Klippel-Trenaunay (S) Maria Antonella Ruffino, Turin, Italy syndrome—report of a series (S) Wen Hsien Hsu, Taipei, Taiwan

This preliminary CX Programme is subject to change

20 Vascular & Endovascular Controversies Update 24–27 April 2018

Novel assessment device for detection of lower limb arterial disease: A Treatment of carotid artery terminal bifurcation and sidewall aneurysms in prospective comparative study (T) Ali Kordzadeh, Broomfield, United Kingdom canines with an expandable, detachable gold metal balloon and coils (S) Kieran Murphy, Toronto, Canada Real-world results of a dynamic scoring device in calcified femoropopliteal vessels (S) John Pigott, Toledo, United States The risk of in-hospital stroke or death is associated with age but not with  The autologous vein bypass to pedal artery branches is the technical sex in patients treated with carotid artery stenting for symptomatic or Sofie Schmid, Munich, Germany border of peripheral bypass for critical limb ischaemia (S) asymptomatic carotid stenosis (T) Achim Neufang, Weisbaden, Germany A long-term observational study on carotid artery treatment (S) Konstantinos Spanos, Larissa, Greece Outcome of percutaneous mechanical thrombectomy compared with catheter-directed thrombolysis in acute and subacute lower limb Bypass for symptomatic in-stent carotid restenosis (S) ischaemia patients (S) Nattawut Puangpunngam, Bangkok, Thailand Francesco Stilo, Rome, Italy New method for assessment the efficiency of revascularisation in patients Result comparison of carotid stenosis treatment between octo- with critical limb ischaemia (S) Gennadii Sheiko, Nizhniy Novgorod, Russia nonagenarians and younger patients (S) Salvatore Alberto Turiano, Catania, Italy The outcomes of patients with end-stage renal disease and critical limb ischaemia (T) Irina Baimatova, Auckland, New Zealand Concomitant prevalence of intracranial and extracranial carotid artery Constance van Laarhoven, Utrecht, Netherlands Choice of the revascularisation method for patients with critical ischaemia aneurysms (T) of lower limbs on the background of metabolic syndrome (T) Anastasia Artemova, St Petersburg, Russia Venous Toe pressure in predicting diabetic foot ulcer healing: a systematic review Catheter-directed fragmentation with local thrombolytic therapy and and meta-analysis (T) Wei-Wen Ang, Singapore anticoagulant therapy in patients with intermediate-high-risk pulmonary Below-the-knee arterial disease management review (T) embolism: Comparison of methods (S) Pavel Ignatenko,Novosibirsk, Russia Claudia Martinez, Dublin, Ireland Catheter thrombolysis and thrombaspiration in treatment of acute deep Comparison of above and below-the-knee inflow in critical limb ischaemia venous thrombosis (T) Viktoriya Tsay, Tashkent, Uzbekistan patients submitted to distal and ultradistal revascularisation using Quality of life and post-thrombotic syndrome after surgical thrombectomy autologus vein grafts (S) José Tiago, Loures, Portugal of acute iliofemoral deep vein thrombosis (S) Integrated treatment strategies for critical limb ischaemia in the octo- Stefan Ockert, Lucerne, Switzerland nonagenarians patients (S) Rosario Tringale, Catania, Italy Low-dose direct oral anticoagulant in the treatment of superficial Can more mean less? Reduction of wound complications using an thrombophlebitis (S) Mosaad Soliman, Mansoura, Egypt extended antibiotic prophylaxis in major lower limb amputations (T) The effect of use of platelet rich plasma (PRP) on venous ulcer size in Daniel Urriza Rodriguez, Ducklington, United Kingdom comparison to the usual method of dressing and compression bandage (T) Short-term outcome of infrapopliteal percutaneous transluminal Mohamed Rizk, Cairo, Egypt angioplasty for isolated infrapopliteal lesions in patients with critical limb Effort vein thrombosis of the upper limb (T) Albert Kota,Vellore, India ischaemia (S) Asser Abd El-Hamid Goda, Cairo, Egypt Incidence and risk factors associated with patients with deep venous thrombosis in a regional university hospital (S) Acute Stroke Altino Ono Morais, São Paulo, Brazil Endovascular stroke treatment of acute tandem occlusion: a single-centre Initial experience of the SIOXX XL stent use in occlusive venous diseases experience (T) Alessio Bozzi, Benevento, Italy (S) Altino Ono Morais, São Paulo, Brazil Safety and efficacy of the Revive thrombectomy device in severe acute Once versus twice daily low molecular weight heparin for the initial ischaemic stroke (S) Roberto Gandini, Rome, Italy treatment of venous thromboembolism: results of a meta-analysis Mimi Li, London, United Kingdom Dual monitoring during carotid endarterectomy using near-infrared (Cochrane review) (T) spectroscopy and stump-pressure (T) Agne Gimzauskaite, Kaunas, Lithuania Deep vein thrombosis diagnostic workup: Five-year results (T) Kyriaki Kakavia, Athens, Greece Completion imaging after carotid endarterectomy (S) Abdurasul Yulbarisov, Tashkent, Uzbekistan Vena cava retrievable filters: “Chronicle of an advertised complication”. One strategy in patients with concomitant severe carotid and coronary or Experience in a Mexican centre of vascular surgery (T) Jesus Emmanuel Arriaga-Caballero, Mexico City, Mexico valve disease that required cardiac surgery (S) Fernando Belcastro, Buenos Aires, Argentina The lady with the swollen head (S) Fahd Chaudhry, Knoxville, United States Patch angioplasty or primary closure following carotid endarterectomy for Safety and effectiveness of VenaBlock; novel endovenous glue system symptomatic carotid artery stenosis: a systematic review (T) vs. infrared laser ELVeS 1470nm, in a treatment of truncal insufficiency of Eline Huizing, Beverwijk, Netherlands superficial veins—a prospective study (S) Tomasz Grzela, Bydgoszcz, Poland Impact of new technique of carotid endarterectomy with autoarterial Implementation of new endovenous treatments of varicosis in the therapy remodelling of bifurcation of the common carotid artery and carotid of lateral embryonic veins in Klippel-Trenaunay Syndrome (S) endarterectomy with patch on change of blood pressure and heart rate Ulrike Huegel, Bern, Switzerland Pavel Ignatenko, Novosibirsk, Russia after operation (S) Catheter-directed thrombolysis for treatment of bilateral Iliofemoral deep A single-centre prospective study using transcarotid artery venous thrombosis with hypoplastic inferior vena cava (T) revascularisation and double mesh stent: Intermediate analysis (S) Mohamed Ismail, Cairo, Egypt María Pilar Lamarca Mendoza, Toledo, Spain Effect of tumescence anaesthesia and patient positioning on junctional Outcomes of carotid revascularisation under different anaesthetic distance during endovenous laser ablation (T) techniques: General or regional/local anaesthesia? (S) Julien Al Shakarchi, Halesowen, United Kingdom Mahmoud Malas, Baltimore, United States Industry sponsored satellites – Pavilion Sponsors During coffee, lunch and tea breaks food and refreshments will be served also in the Upper and Lower Main Auditoriums. Tuesday 24 April Tuesday 24 April Wednesday 25 April Thursday 26 April Upper Main Auditorium Lower Main Auditorium Upper Main Auditorium Upper Main Auditorium Gore Satellite Boston Scientific Satellite Gore Satellite Symposium Getinge Satellite Symposium Symposium COFFEE BREAK Symposium COFFEE BREAK COFFEE BREAK COFFE BREAK Medtronic Satellite Medtronic Satellite Medtronic Satellite Symposium Vascutek Satellite Symposium Symposium LUNCH BREAK Symposium LUNCH BREAK LUNCH BREAK LUNCH BREAK Lower Main Auditorium Vascutek Satellite Symposium LUNCH BREAK

21 EDUCATION

INNOVATION

EVIDENCE

Key dates

Early bird registration ends: 25 February 2018 Save the CX 2018 dates: 24–27 April 2018

General enquiries

Charing Cross Symposium, 526 Fulham Road, London SW6 5NR, United Kingdom Tel: +44 (0) 20 7736 8788, Fax: +44 (0) 20 7736 8283, Email: [email protected]

Exhibitor information

Nathalie Fortin Tel: +44 (0) 20 7736 8788 Fax: +44 (0) 20 7736 8283 Email: [email protected] Registration and Hotel Booking Form 24–27 April 2018

Please register online at www.cxsymposium.com or complete this form and return to: BIBA Medical, 526 Fulham Road, London, SW6 5NR, United Kingdom Fax: +44 (0)20 7736 8283 Tel: +44 (0)20 7736 8788 Email: [email protected]

Participant information (block capitals) First name Last name Title Institution or company Address Post code City Country Direct email (please write clearly) Telephone Mobile

Speciality q Vascular surgeon q Vascular physician q Nephrologist q Research/education q Other (please specify) q Interventional radiologist q Vascular technologist/nurse q Podiatrist q Industry participant q Interventional cardiologist q Cardiothoracic surgeon q Diabetologist q Other clinician (please specify) q Angiologist q Transplant surgeon q Wound care specialist

Rates CX 4 DAY RATE CX 1 DAY RATE (ACCESS ALL AREAS, INCLUDING VASCULAR ACCESS AND VENOUS WORLD) (ACCESS ALL AREAS FOR TUESDAY, WEDNESDAY OR THURSDAY) Early bird* Standard rate Late/onsite registration** Early bird* Standard rate Late/onsite registration** Full registration £695 q £795 q £895 q £295 q £345 q £385 q Junior doctor registration1 £345 q £395 q £445 q £150 q £180 q £195 q

Vascular technologist/ nurse1 £145 q £175 q £195 q £75 q £95 q £105 q Please select day: Tuesday q Wednesday q Thursday q Note: The 4-day rate includes the CX symposium book Note: The 1-day rate(s) excludes the cx symposium book

* Early bird rates are valid on applications received before midnight on 25th February 2018. CX ACUTE STROKE CONSENSUS - FRIDAY

** Late/onsite registration applies after Friday 20th April 2018. Early bird* Standard rate Late/onsite registration** 1 This fee is subject to verification of status in the form of a letter from your head of department. £95 q £115 q £125 q

Note: Friday only. Excludes CX symposium book. CX bag will be subject to availability.

Terms • Rates are inclusive of VAT at 20%. provide justification of status in the form of a letter 26th April), the Venous Edited Cases, Venous Main • Credit card payments received via mail or telephone from your department head or a work pass copy. Programme (Tuesday 24th April) and the Venous will be processed in GBP and debited at the current • Registrations will not be confirmed unless we Abstract Presentations. rate of exchange receive the full contact details of the delegate, • The Vascular Access Masterclass (plenary session) • Cancellation policy: Cancellation up to 24th March including the direct email address. takes place on Wednesday 25th and the Workshop 2018 will be subject to a 20% administration charge. • Industry participants should register with a full (hands-on skills) is on Thursday 26th. There is no We regret that refunds after this date will not be registration. longer a separate Vascular Access registration type available. so if you wish to attend these sessions you will need • Venous World in 2018 incorporates the two-day to buy the full 4-day package. • Junior doctors, technologists and nurses should Venous Workshop (Wednesday 25th and Thursday

Payment

q Credit card: Please charge my credit card according to the amount selected above (On back of card) Card type: VISA / MASTERCARD / DELTA / MAESTRO (United Kingdom ONLY) / AMEX Please specify (4 digits for Amex)

Card number | | | Expiry date | 3 digit security code | Issue no

Cardholder’s name Cardholder’s signature q Payment by cheque enclosed: Please make cheque in GBP payable to BIBA MEDICAL LTD q Payment by bank transfer: Proof of payment must accompany the registration form if paying via bank transfer

Bank details

Account No: 01148583 Account name: BIBA Medical Ltd Sort code: 40-02-35 IBAN No: GB67 HBUK 40023501148583 Swift Code: HBUKGB4140J Address: HSBC, 357 Upper Richmond Road West, London SW14 8QW, United Kingdom Please include a copy of your bank transfer. Quote your surname as reference. VAT Registration Number 730681150. Ref: CX2018-3

23 Years of Looking Forward - Plenary Programme

Please book online at www.cxsymposium.com or complete this form and return to: BIBA Medical, 526 Fulham Road, London, SW6 5NR, United Kingdom Fax: +44 (0)20 7736 8283 Tel: +44 (0)20 7736 8788 Email: [email protected]

Participant information (block capitals) First name Last name Title Institution or company Address Post code City Country Direct email (please write clearly) Telephone Mobile

Dorsett Shepherds Bush

Hilton London Kensington Copthorne Tara Hotel

K West

Hilton London Olympia

Holiday Inn High Street

Grand Hall Novotel London West Olympia Millennium Baileys Hotel Millennium K+K Hotel George Gloucester Hotel K+K Hotel George DoubleTree by Hilton

Hotels within walking distance Hotels easily accessible via public transport q Single q Double q Single q Double Holiday Inn High Street q £145 £155 Copthorne Tara q £146 £156 Millennium Baileys Fully Booked £221 £234 Dorsett Shepherds Bush q £185 £195 Millennium Gloucester q £209 £221 Hilton London Kensington q £218 £228 Hilton Olympia q £220 £230 K West q £240 £250 Notes K+K Hotel George q £190 £200 1. There will be a limited shuttle bus service from the following hotels to and from Olympia: Millennium Gloucester, Copthorne Tara and the Hilton Kensington. Novotel London West q £190 £200 2. All rates are inclusive of VAT at 20% and breakfast. 3. All hotel rooms are held against your credit card and must be paid for on departure. Booking details

Arrival date | | Departure date | |

Number of nights Rate per night £ . Total due £ . (Based on first preference)

Payment q Credit card: Please charge my credit card with the amount in the Total due section above Card type: VISA / MASTERCARD / DELTA / MAESTRO (United Kingdom ONLY) / AMEX Please specify

Card number | | | Expiry date | 3 digit security code | Issue no

Cardholder’s name Cardholder’s signature Ref: CX2018-3

24 Vascular & Endovascular Controversies Update